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ABSTRACT 
 
NOVEL APPROACHES TO EVALUATE AND ENHANCE NEONATAL 
CALF GASTROINTESTINAL HEALTH AND DEVELOPMENT 
FERNANDA TRINDADE DA ROSA 
2019 
Physiological adaptations of the gastrointestinal tract (GIT) epithelial cells as well 
as methods to manipulate early life GIT microbiota colonization during the neonatal 
stage, is of great importance to the dairy industry. The first objective of this research was 
to optimize a method based on evaluation of bovine transcripts in fecal RNA via RT-
qPCR using L-selectin (SELL) as a marker for polymorphonuclear leukocytes (PMNL), 
keratin 8 (KRT8) and fatty acid binding protein 2 (FABP2) for GIT enterocytes, and tight 
junctions in fecal RNA and GIT sections in dairy calves. To test the reliability of the fecal 
RNA method, fecal and PMNL samples from neonatal calves were used. The expression 
of KRT8 was greater in fecal RNA than in PMNL. In contrast, a greater SELL expression 
was observed in PMNL. In another study, postmortem GIT and feces samples were 
collected from healthy calves for total RNA isolation. Overall, the expression of FABP2 
and KRT8 was similar between fecal RNA and the lower GIT. Taken together, these 
results provide further evidence that the fecal RNA method can potentially be used as a 
tool to evaluate molecular adaptations of the GIT in dairy calves. The second objective 
was to evaluate the effects of early life fecal microbiota transplantation (FMT) from 
healthy adult donors on health and performance of neonatal dairy calves. To test the 
effects of FMT, newborn calves were subjected to 1×/d inoculations with 25 g of fecal 
xv 
 
donor material mixed in the milk replacer from 8 to 12 d of age. Results from this study 
demonstrated that calves subjected to FMT tended to have greater body weight than 
control calves. The liver function marker paraoxonase was greater in the blood of FMT 
calves than control at 3wk of age. These results suggest that FMT in neonatal calves has 
positive effects not only on growth performance but also in mediating liver function. 
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INTRODUCTION 
 
Neonatal dairy calves experience several challenges early in life, including 
adaptation to an extrauterine life, where animals have to adapt from an umbilical-nutrient 
mode of delivery to ingest milk and food from buckets or bottles, as well as thermoregulate 
their own body and being exposed to a new environment loaded with pathogens. After 
birth, the gastrointestinal tract (GIT) undergoes morphological and functional 
adaptations, which start with the ingestion of colostrum, affecting the gastrointestinal 
motility as well as the acquisition of passive immunity (Guilloteau et al., 1997, Blum and 
Hammon, 2000). In addition to the gastrointestinal maturation, the calf has to adapt to a 
new pathogen-rich environment and has to transition from pre-ruminant to ruminant 
during the weaning period. Together, these factors can prone calves to develop diarrhea 
due to the absorption of endotoxins from the GIT or the translocation of microbes 
(Constable, 2004). Because of these early life challenges neonatal dairy calves have to 
overcome, enteric infections are the leading cause of mortality in preweaned dairy calves 
in the US (Berchtold, 2009). Additionally, diarrhea is a major cause of economic loss to 
dairy producers, including cost of antibiotics, reduced growth, and increased age at first 
calving (Windeyer et al., 2014). Fecal score systems are commonly used by researchers 
and dairy producers to keep track and identify animals at risk of developing diarrhea. 
More sophisticated methods such as microscopy, end-point PCR, and bacterial culturing 
have been used to identifying specific strains of infectious pathogens. However, these 
analyses lack information on the actual biological adaptations the GIT undergoes during 
the onset of diarrhea. The GIT epithelial cells besides the function of absorption of 
nutrients, also act as a barrier to harmful pathogens, and the exfoliation of these cells has 
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been associated with an intestinal natural turnover process to preserve tissue structure 
(Kaeffer, 2011). It has been estimated that in mammals such as humans, 1010 cells are 
shed daily from the small intestine (Donovan et al., 2014). Epithelial cells can be isolated 
from different body fluids (i.e., urine and feces), which it is a non-invasive technology 
that can be used instead of performing tissue biopsies and postmortem tissue analysis 
(Kamra et al., 2005). 
The high turnover of cells occurring in the small intestine suggests that at least a 
small portion of those exfoliated cells are viable for downstream molecular biology 
applications. A noninvasive mRNA-based method as a highly sensitive technique was 
originally used for detecting molecular biomarkers of colon cancer in rats (Davidson et 
al., 1995, Chapkin et al., 1998) and later for intestinal development and function in adult 
humans (Davidson et al., 2003, Zhao et al., 2009). This method has been used to study 
nutritional regimens in humans, using stool samples to isolate exfoliated cells from the 
GIT  (Kaeffer et al., 2007), as well as to quantify intestinal gene expression profiles in 
developing infants (Chapkin et al., 2010). In the latter, Chapkin et al. (2010) were able to 
differentiate between neonates that were breastfed and formula-fed by their different 
transcriptomic profiles. 
 In this context, our group demonstrated that transcriptional changes of the GIT to 
inflammatory conditions (e.g., diarrhea) could be evaluated by alternative methods such 
as RNA isolated from feces of neonatal dairy calves (Rosa et al., 2018). In that study, 
intestinal exfoliated cells in fecal samples of neonatal dairy calves are viable for 
downstream molecular applications. The expression of genes related to inflammatory 
pathways as well as cell membrane transporters detected in the fecal RNA was associated 
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with blood biomarkers of inflammation at the time point where the calves had the greatest 
fecal score (i.e., scours). However, the possibility to use the above method to investigate 
intestinal gene expression alterations in dairy calves needed further insights and 
evaluation. 
The GIT microbial colonization and symbiosis are essential for the development 
and physiology of mammals, including neonatal calves (Alipour et al., 2018). The GIT 
microbiota has several roles in nutrition, energy metabolism, host defense, and immune 
system development. Several factors can potentially affect the newborn intestinal microbial 
complexity and maturation including intrauterine environment (i.e., maternal microbiome), 
dystocia as well as postnatal factors including environment, diet, antibiotic use, and in the 
case of neonatal calves colostrum intake and quality (Oikonomou et al., 2013, Perez-
Muñoz et al., 2017). Taken together, these several factors suggest that early life 
interventions on the gut microbiota can be a key factor in manipulating GIT colonization in 
neonatal calves, and therefore improve their health and growth by reducing the 
susceptibility to enteric infections. For instance, fecal microbiota transplantation (FMT), 
which is the transfer of microbiota via inoculation (i.e., oral administration, endoscopy, 
colonoscopy) present in the fecal material of a healthy-selected donor into a recipient, can 
potentially restore or shift the GIT microbial composition (de Groot et al., 2017). In human 
medicine, FMT has been extensively used to treat individuals suffering from different types 
of infections, including inflammatory bowel disease (Ponte et al., 2015, Khanna et al., 
2017). However, in the animal production, there are still many gaps in knowledge when it 
comes to utilizing FMT in livestock animals, where very few studies have been conducted, 
primarily in companion animals (Pereira et al., 2018), neonatal piglets (Hu et al., 2018b), 
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and broiler chickens (Siegerstetter et al., 2018); however, to date, there are no studies that 
performed FMT in dairy calves.  
The two overall goals of this research are to further validate and optimize a non-
invasive fecal RNA method to investigate transcriptomic changes in the GIT neonatal 
calves, and to evaluate the effects of an early life fecal microbiota transplant on growth and 
health performance of neonatal dairy calves.  
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CHAPTER 1. LITERATURE REVIEW 
 
Neonatal health and immunity 
 
In dairy calf development, a major focus of research has been the maturation of 
the rumen (Baldwin et al., 2004). However, there is a critical period prior to the solid feed 
intake, and consequently, the rumen development and maturation, that is characterized by 
high susceptibility to disease. In this period, the gastrointestinal tract undergoes several 
changes such as an increase in permeability and functionality (Steele et al., 2016b). The 
newborn calf has to adapt its digestive system from an umbilical nutrient delivery during 
the fetal period to ingestion of bottle- or bucket-fed milk. After birth, the GIT undergoes 
morphological and functional adaptations, which start with the ingestion of colostrum, 
affecting the gastrointestinal motility as well as the acquisition of the passive immunity 
(Guilloteau et al., 1997, Blum and Hammon, 2000). In addition to the gastrointestinal 
maturation, the calf has to adapt to a new environment, which is loaded with pathogens, 
thermoregulate its own body, and transition from pre-ruminant to ruminant during the 
weaning period. After birth, both microbial and gastrointestinal epithelial cells (GEC) 
maturation are influenced by many factors, including diet, length of gestation, and 
antibiotic usage. The latter has been closely associated with a fundamental disruption of 
the normal intestinal flora (i.e., dysbiosis), and consequently, linked with diseases in both 
humans and animals (Francino, 2015). Besides the several challenges described above 
that a newborn calf goes through during the first 4 weeks of life, factors affecting early 
colonization of the neonate microbiome can fundamentally challenge infants and put 
them at risk for immune and metabolic disorders. In newborn calves, intestinal disorders 
are common events during the neonatal stage (from birth to weaning), as well as, during 
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the preweaning and weaning period leading to diarrhea or calf scour, which is the leading 
cause of mortality in neonatal dairy calves in US during the first 4 weeks of life 
(Berchtold, 2009). Indeed, according to the National Animal Health Monitoring System 
(NAHMS), scours or other digestive problems during the pre-weaning stage account for 
57% of calf mortality in the US. Additionally, diarrhea is a major cause of economic loss 
to dairy producers, including the cost of antibiotics, reduced growth, and increased age at 
first calving (Windeyer et al., 2014). Furthermore, NAHMS also reported high antibiotic 
usage for the treatment of calf scours. 
Neonatal calf scours are frequently observed from 3 to 21 d of age, but its onset 
and duration are determined by the number of pathogens involved and the immune 
condition of the animal (Blum, 2006). In mild-diarrhea conditions, loss of extracellular 
fluids and electrolytes can take place; however, during severe diarrhea conditions, body 
weight loss due to dehydration and cellular damage of the GIT epithelium due to 
inflammation can be observed (Blum and Hammon, 2000). The major pathogens that 
have been identified as contributing to enteric challenge in calves and consequently, to 
the development of calf diarrhea include Escherichia coli K99 (E. coli), Rotavirus, 
Coronavirus, Salmonella spp., and Cryptosporidium parvum (Izzo et al., 2011, Cho and 
Yoon, 2014). 
All these events during the neonatal stage of calves are regulated by an interaction 
between infectious pathogens, the immune status of the calf, and the environment. 
Despite major advances in dairy calf rearing, the neonatal development has many gaps in 
the understanding of the transitional fetal/neonatal physiology, and the transition from 
pre-ruminant to ruminant. For most dairy operations, calves represent the next generation 
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of milk producing animals. However, keeping young calves healthy and growing is a 
complex task. Therefore, understanding these physiological changes and the 
transcriptional alterations involved within the gastrointestinal tract that might cause or 
induce inflammation, which can affect the animal systemically can be used as a tool to  
strategically intervein and manipulate the gastrointestinal tract of dairy calves during the 
susceptible period from birth to weaning resulting in health improvement and 
productivity. 
Immune status of the neonatal calf and the impact on health 
 
The immune status of neonatal calves can be characterized as dysfunctional. 
Although all essential immune components are present in neonates at birth, many of the 
components are not functional until calves are at least 2 to 4 weeks of age and might 
continue to develop until puberty (Chase et al., 2008).  
In bovine, since antibodies don’t cross the placenta (Peter, 2013), the 
immunoglobulins (IgG) transferred from the cow to the calf through the colostrum are 
essential for the newborn’s survival by providing the passive immunity. Poor 
immunoglobulin transfer is called failure of passive transfer (FPT) and is linked to 
increased neonatal morbidity and mortality in dairy calves (Torsein et al., 2011). The 
absorption of intact macromolecules across the intestinal epithelium into the neonatal 
circulation is possible for approximately 24 hours after birth (Arthington et al., 2000). 
There is evidence that around 12 h after birth, the intestinal enzyme secretion starts to 
increase, in addition to the intestinal cell turnover, which reduces the IgG absorption 
(Quigley and Drewry, 1998). However, there is a gap between the passive immunity 
provided by colostrum and the acquisition of the neonate active immunity. Considering 
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that passive immunity acquired from colostrum remains active only up to approximately 
21 days of age, the neonatal stage encompasses a wide window of high susceptibility to 
infections and illness, and consequently immune challenges (Kampen et al., 2006, 
Ranade et al., 2014). 
At birth, neonates have neutrophil and macrophage (innate immune cells) activity 
reduced, which improves after colostrum ingestion due to the maternal transfer of 
immunoglobulins, immune cells, and cytokines. On the other hand, maternal immunity 
interference is a challenge regarding vaccine development for neonatal calves. Several 
maternal antibodies have a half-life of 28 days (Fulton et al., 2004), therefore the timing 
for administrating a parenteral vaccine needs to take in consideration the timeframe 
where the maternal antibody is in a low level to produce an immune response to the 
vaccine (Cortese, 2009). Additionally, the cow production of estrogen and cortisol prior 
to parturition can affect the immune response of the newborn calf by suppressing the cell-
mediated response (Chase et al., 2008).  
Intestinal functionality and integrity 
 
The GIT is a dynamic and complex environment with a microbiologically active 
ecosystem (i.e., microbiota) and a heightened immune activity comprising non-
hematopoietic (e.g., epithelia, Paneth cells, goblet cells, etc.) and hemopoietic cells (e.g., 
macrophages, dendritic cells, T-cells, etc.) (Maldonado Galdeano et al., 2019). 
The small intestine encompasses a dual function: a) provide selective absorption 
of nutrients; b) provide a barrier against harmful pathogens within the intestinal lumen 
(Yu et al., 2012). The intestinal microbiota does not interact directly with the intestinal 
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epithelial cells; however, the feed intake, the host-microbiota, and the host mucosa 
interact with each other supporting the health of the GIT tract, and consequently the 
animal growth and performance. Celi et al. (2017) defined the gastrointestinal 
functionality as a state where diet, effective digestion and absorption, stable microbiota, 
effective immune system, intestinal mucosa, and neuroendocrine function of the GIT 
interact in a symbiotic equilibrium maintaining the GIT homeostasis and constraining 
intestinal dysfunction. Thus, intestinal permeability and GIT barrier play a crucial role in 
the GIT physiology and overall gut health. 
Intestinal structure and immune system 
 
The intestinal epithelium exhibits numerous physical adaptations to separate the 
host connective tissue from the external environment (Guilloteau et al., 1997). Four 
important cell types are defined, namely absorptive (enterocytes in the small intestine, 
and colonocytes in the large intestine), muco-secreting cells (goblet cells), 
enteroendocrine (function in peptide hormone secretion), and Paneth cells (secretory 
granules). Under healthy conditions, the renewal of these cells within the GIT occurs 
every 2-7 days by the GIT stem cells localized in the crypt base of the GIT epithelium, 
however during tissue damage period, the epithelial shed increases (Brittan and Wright, 
2004).  
Small intestinal absorptive cells (enterocytes) are columnar epithelial cells, which 
form crypts and villi to increase surface area for absorption (Steele et al., 2016a). the 
mucosal epithelium consists in a mucus-glycocalyx layer protecting the enterocytes, 
which is in continuous contact with commensal and harmful microorganisms, this mucus 
layer is produced by the goblet cells (mucus-secreting cells), serving as a physical barrier 
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(Peterson and Artis, 2014). Intestinal epithelial cells are covered with two layers of 
mucus, the firmly adherent layer that is closest to the epithelium and the loosely adherent 
layer that is the outer layer (Steele et al., 2016a). The mucus layer is predominantly 
mucin-rich layer, whereas the mucin 2 (MUC2) produced by the goblet cells is the most 
abundant mucin in the mammalian intestine (Chen et al., 2015). Intestinal epithelial cells 
also produce antimicrobial proteins, called AMPs, and secrete them into the mucus layer. 
The AMPs produced by these cells include the lysozyme, which breaks down cell wall 
components, lactoferrin, which sequesters iron needed for bacterial growth, and alpha-
defensins when exposed to bacterial products. (Gassler, 2017). In addition to the AMPs in 
the mucus layer, secreted immunoglobulin A (IgA) antibodies produced by B cells in the 
Peyer’s patches and throughout the intestinal lamina propria are actively transported and 
translocated by polymeric immunoglobulin receptor (pIgR) located on the basolateral 
membrane of enterocytes.  The IgA is then transported through the enterocytes, where the 
pIgR is converted into the secretory piece and added to the dimeric IgA prior to secretion 
into the intestinal lumen. The secretory IgA limits the association of pathogens with the 
intestinal epithelia. The IgA antibody is a major functional component of the humoral 
adaptive immune system, specifically at mucosal sites. The antibodies are predominantly 
produced in the intestinal lamina propria by plasma cells following B cell differentiation 
(Chase and Kaushik, 2019). Also, the commensal microbiota present in the GIT is 
essential for the mucus layer integrity, including the thickness of the mucosal barrier as 
well as the mucosal interaction with the host-microbiota, which stimulates a state of 
inflammatory recognition needed for the maintenance of the intestinal homeostasis 
(Galdeano and Perdigon, 2004).  
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The enterocytes are the most abundant epithelial cells type lining the 
gastrointestinal tract with the primary function of nutrient absorption through active and 
passive transport and brush border enzyme activity (Peterson and Artis, 2014). However, 
these cells express toll-like receptors (TLR) in their membrane by which upon pathogen 
recognition can initiate a pro-inflammatory response in the GIT by producing specific 
cytokines. In the case of neonates, the intestinal enterocytes are immature at birth and 
mature within the first week after birth, as indicated by the loss of vacuoles along the 
proximal-distal axis, which contributes to intestinal barrier closure (Prgomet et al., 2007).  
Enteroendocrine cells link central and enteric neuro-endocrine systems through 
the secretion of peptides hormones that act locally on the nervous system of the intestinal 
lining. Such secretion regulates food intake, GIT motility, and glucose metabolism (Cani 
et al., 2013). Beneath the basolateral surface of the GIT epithelium, there is the lamina 
propria surface, which hosts immune cells such as macrophages, natural killer cells, mast 
cells, dendritic cells, as well as, B cells and T regulatory cells (Chase and Kaushik, 2019). 
Intestinal permeability 
 
The establishment of an epithelial barrier requires the formation of 
morphologically distinct tight junctions. Tight junctions are adhesive junctional protein 
complexes between epithelial cells that connect each other, forming a paracellular barrier, 
which facilitates the passage of ions and solutes through the intercellular space while 
preventing the translocation of luminal antigens, microorganisms, and toxins (Bischoff et 
al., 2014). Tight junctions determine the extent and maintain distinct apical and 
basolateral membrane domains in epithelial cells, thereby tightening and maintaining the 
permeability capacity of the intestine (Fanning et al., 1998). Tight junctions are crucial 
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for the integrity of the epithelial barrier function.  Among the tight junction proteins 
families, there are 3 transmembrane proteins: occludin, claudin, and junctional adhesion 
molecules (JAM). Tight junction protein ZO-1, claudin 1, and 4 are commonly abundant 
in the epithelial cell layers (Kiuchi-Saishin et al., 2002, Langbein et al., 2002). When the 
claudin-1 gene was knocked out, the epidermal barrier failed to prevent water loss 
(Furuse et al., 2002). Pro-inflammatory cytokines such as TNF-α (tumor necrosis factor-
α) and IFN-γ (interferon-γ) cause disruption of the tight junction barrier resulting in 
increased paracellular permeability in intestinal monolayers (Al-Sadi et al., 2009). Anti-
inflammatory cytokines such as IL-10 (interleukin-10) and TGF-β (transforming growth 
factor) maintain tight junction integrity function (Forsyth et al., 2007). Inflammation 
associated with gastrointestinal disorders is the major inducer of tight junction 
dysregulation, resulting in increased intestinal permeability (Kvidera et al., 2017). 
Pathogenic recognition in the intestinal epithelium and signaling response 
 
The intestinal immune system has the ability to distinguish between inducing 
either immune responses against harmful antigens or tolerogenic responses towards 
antigens derived from nutrients and beneficial bacteria (Maynard et al., 2012). However, 
when the mucosal barrier becomes disrupted, bacteria and/or bacterial products can 
invade the adjacent tissues and are sensed by antigen-presenting cells, such as dendritic 
cells and macrophages. These cells migrate to the lymphoid follicles in the Peyer’s 
patches or to gut-draining mesenteric lymph nodes, where they present the antigens to 
naive T cells leading to their activation and expansion. The resulting effector T cells 
eventually exit the mesenteric lymph nodes and migrate to the gut interstitium (Antoni et 
al., 2014). Once in the intestinal lamina propria, they re-encounter their specific antigen 
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presented by antigen-presenting cells, which initiates a rapid inflammatory response with 
the production of proinflammatory cytokines. 
Although commensal microbiota is essential for immunological tolerance, the 
immune system needs to differentiate between commensal bacteria and pathogenic 
bacteria. Therefore, receptors present in the membrane of epithelial and lymphoid cells of 
the small intestine regulates this differential recognition. These receptors have been 
named pattern recognition receptors (PRRs), and the structures they sense are termed 
pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns 
(DAMPs). Several classes of PRRs have been described, including toll-like receptors 
(TLRs) and C-type lectin receptors (CLRs) (Brubaker et al., 2015). Under non-
inflammatory conditions, TLR signaling leads to tolerance towards luminal pathogens 
through the down-regulation of pattern-recognition receptors and promotes mucosal 
wound healing (Abreu, 2010). When intestinal macrophages and dendritic cells sense 
PAMPs, pathogen signaling pathways including the nuclear factor kappa light chain 
enhancer of activated B cells (NF-κB) are activated inducing pro-inflammatory cytokines 
production such as interleukin 1 (IL1), interleukin 6 (IL6) and tumor necrosis factor alpha 
(TNFA), and chemokines, such as interleukin 8 (IL8) (Ceciliani et al., 2012). 
Neonatal calf microbiota 
 
Early neonatal GIT microbiome colonization and development begins with 
maternal microbiome seeding begins before parturition. The traditional “paradigm” that 
the fetus develops in a sterile environment has been challenged in the past years (Aagaard 
et al., 2014). 16S ribosomal RNA sequencing demonstrated that bacterial species from 
the phyla Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes, and Fusobacteria were 
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found to exist within the human placental basal plate (an area once thought to be sterile) 
(Aagaard et al. 2014). In another study, cesarean-born babies deprived of maternal 
vaginal microbial transfer at birth are predisposed to have health issues (Dominguez-
Bello et al., 2010).  
GIT microbial colonization in a newborn calf includes the vaginal microbiome 
and the proximity of the birth canal (Oikonomou et al., 2013). Colostrum and milk 
microbiota may also influence such colonization. Microbial diversity increases with 
growth, age, and dietary adaptations in calves (Malmuthuge and Guan 2017).   
Lower gastrointestinal tract microbial colonization: Mayer et al. (2012) attempted 
to investigate first colonizers in newborn calves; however, this study was not able to 
validate such findings in the meconium samples with placental transfer, but the microbial 
composition identified was associated with the rectal bacterial flora of the dam. In 
another study to investigate the initial colonization of GIT of newborn calf  (Klein-Jöbstl 
et al. 2019) demonstrated that Proteobacteria were the most abundant in calf feces over 
time. However, a significant shift in the microbial composition was observed during the 
first 48 hours after birth, whereas Actinobacteria and Bacteroidetes decreased within 12 
hours after birth, while Proteobacteria and Firmicutes increased from 24 to 48 hours 
after birth. Furthermore, the same study showed the presence of operational taxonomic 
units (OTUs) with E. coli in all the fecal samples during all the time points, which is in 
agreement with previous studies that demonstrated E. coli colonization in the calf rectum 
24 hours after birth (Alipour et al., 2018). 
Most of the intestinal microbiota studies in neonatal calves have focused on 
identify and classify the fecal microbiota as a representative population of the GIT 
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microbiota (Meale et al., 2017a). The microbial population in the gastrointestinal tract of 
neonatal calves is primarily important for the stimulation of the inflammatory mechanism 
within the intestinal lumen, as discussed previously. The bacteria composition throughout 
the GIT (i.e., rumen, jejunum, ileum, cecum, and colon) in neonatal bull calves (i.e., 3 wk 
of age) varied in bacterial composition depending on the region, whereas ruminal 
samples and large intestine had high levels of Bacteroidetes while the small intestine had 
high levels of Firmicutes. 
Forestomach microbial colonization: The majority of the microbial investigations 
on the forestomach of calves have been focused on the rumen maturation rather than 
omasum and abomasum evaluation. The rumen colonization of calves (pre-ruminant) is 
mainly colonized by anaerobic bacteria by the second day of life, and the cellulolytic 
bacteria population reported to be stabilized within the first week of life. The early rumen 
bacterial species consist of the genera Propionibacterium, Clostridium, 
Peptostreptococcus, and Bifidobacterium, while Ruminococcus species dominated the 
cellulolytic bacterial population (Malmuthuge et al., 2015) . Additionally, bacteria that 
are essential for mature rumen function such as methanogens, fibrolytic bacteria, or 
Proteobacteria have been detected as early as 20 minutes after birth (Guzman et al., 
2015), and 24 hours after birth, prior to any ingestion of solid feed (Jami et al., 2013). 
The findings with rumen microbial colonization in neonatal calves suggest that not only 
is early microbiota colonization essential for the rumen development but might also play 
a role in microbial metabolic products involved in the early immune development (Li et 
al., 2012). This also raised the need to investigate further if such inoculations could be 
associated with prenatal exposure, including maternal microbiome (Meale et al., 2017a). 
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Collectively, these studies and findings suggested that microbial diversity 
throughout the GIT of calves is affected during the preweaning period and can be 
partially attributed to the increase in solid feed intake. However, the incidence of 
infectious disease during the first 4 wk of life and the use of antibiotics for treatment of 
calf diarrhea were also associated with microbial shift (i.e., reduced microbial diversity in 
calves with scours) (Meale et al., 2016, Meale et al., 2017b).  
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RATIONALE AND OBJECTIVES 
 
The overall goal of this project was to improve the understanding of the 
physiological and transcriptional alterations in the gastrointestinal tract (GIT) of dairy 
calves during the most susceptible period for enteric infections, the neonatal stage. To 
evaluate calf neonatal overall health status and performance, we attempted to validate and 
optimized two approaches: a) fecal RNA as a non-invasive technique to study 
transcriptional changes in the gastrointestinal tract of dairy calves during healthy and 
inflammatory conditions; b) fecal microbiota transplant (FMT) as a tool for microbiota 
manipulation in neonatal calves. 
Rosa et al. (2018) was the first attempt to utilize the fecal RNA method to 
evaluate biological adaptations of the gastrointestinal tract of dairy calves through gene 
expression analysis. However, a limitation in this study is the current lack of data 
indicating how the transcriptomic profile observed in fecal RNA mirrors that in specific 
sections of the GIT. Additionally, fecal RNA isolation remains a challenge due to the 
potential enrichment of bacterial RNA and ribosomal RNA, which can create a dilution 
effect on the targeted eukaryotic RNA and consequently dampened the sensitivity of the 
fecal RNA method. Therefore, the objectives of our research on this topic regarding to 
the fecal RNA as a non-invasive method to investigate GIT adaptations study were: 1) to 
evaluate the potential enrichment of immune cells and GIT epithelial cells measured 
through the transcription of target genes for both immune and epithelial cells in RNA 
isolated from fecal samples compared with RNA isolated from blood polymorphonuclear 
lymphocytes of neonatal dairy calves; 2) to compare the transcription of gene markers for 
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GIT epithelial cells, fatty acid binding protein 2 (FABP2) and cytokeratin 8 (KRT8) in 
fecal RNA against several GIT sections in dairy calves.    
The intestinal microbiota plays an important role in animal health. An imbalance 
in the GIT microbiota can make animals more prone to develop diarrhea and other 
diseases. The use of the fecal microbiota transplantation method in a controlled clinical 
trial was first reported in 2013 to be an effective treatment for Clostridium difficile 
infection in humans (van Nood et al., 2013). To our knowledge, the fecal microbiota 
transplantation has not been performed or validated in neonatal dairy calves previously. 
Therefore, we aimed to perform a fecal microbiota transplantation in neonatal dairy 
calves and to evaluate the effects on health parameters, including inflammatory biomarkers 
and overall animal growth.  
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CHAPTER 2. COMPARATIVE GENE EXPRESSION ANALYSIS ON THE 
ENRICHMENT OF POLYMORPHONUCLEAR LEUKOCYTES AND 
GASTROINTESTINAL EPITHELIAL CELLS IN FECAL RNA FROM 
NONDIARRHEIC NEONATAL DAIRY CALVES 
 
This chapter was published as: Rosa, F., and Osorio, J.S. 2019. Comparative gene 
expression analysis on the enrichment of polymorphonuclear leukocytes and 
gastrointestinal epithelial cells in fecal RNA from nondiarrheic neonatal dairy calves. J. 
Dairy Sci. 102(8):7464-7468. https://doi.org/10.3168/jds.2018-16074. 
 
ABSTRACT 
 
Increased understanding of the biology of the gastrointestinal tract (GIT) in 
neonatal dairy calves during their adaptation to an extrauterine environment will decrease 
health problems such as diarrhea while increasing feed efficiency and average daily gain 
in preweaned dairy calves. Within this context, a noninvasive method, based on fecal 
RNA, to study the GIT in neonatal dairy calves through the isolation of RNA from fecal 
samples for quantitative reverse-transcription PCR analysis can provide valuable 
information on GIT biological adaptations during the preweaning period. We aimed to 
evaluate the potential enrichment of RNA from immune cells or GIT epithelial cells 
during fecal RNA isolation. Eight neonatal Holstein calves less than 3 wk old (14.9 ± 5.5 
d of age at sampling ± SD) and a fecal score of 2.0 ± 0.7 (mean ± standard deviation) 
were used. During a single sampling, fecal and blood samples were taken simultaneously 
from each calf before the morning feeding. Fecal samples were immediately frozen in 
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liquid nitrogen until RNA isolation, whereas polymorphonuclear leukocytes (PMN) were 
isolated from blood samples before RNA isolation. A quantitative reverse-transcription 
PCR analysis was performed using a single standard curve composited of equal amounts 
of all samples including cDNA from fecal and PMN. The genes myeloperoxidase (MPO) 
and L-selectin (SELL) were selected for their specific known function in PMN, whereas 
keratin 8 (KRT8) and aquaporin 3 (AQP3) have been associated with epithelial 
enterocytes. Our results showed a contrasting gene expression profile between PMN and 
fecal RNA; whereas greater mRNA expression of SELL was observed in PMN, a greater 
KRT8 expression was observed in fecal RNA. The mRNA expression of AQP3 tended to 
be greater in PMN than fecal RNA. Additionally, MPO was not amplified in fecal RNA. 
Our findings suggest that under nondiarrheic conditions RNA isolated from stool samples 
of neonatal dairy calves will have a considerable number of GIT epithelial cells, which 
confirms the reliability of this method under these conditions. However, further research 
needs to be done to determine if the same effects are observed during diarrhea or 
throughout the preweaning period of dairy calves. 
Key words: Fecal RNA, gene expression, polymorphonuclear leukocytes, dairy calf 
INTRODUCTION 
 
The gastrointestinal tract (GIT) is a complex system with multiple functions 
including digestion and absorption of nutrients, protecting the host from a constant 
presence of microorganisms, toxins, and other chemicals in the lumen. In newborn 
calves, such functions and complexity are well known to be partially influenced by 
exogenous nutritional and nonnutritional factors (i.e., bioactive compounds) that are 
ingested with colostrum (Ontsouka et al., 2004). The latter effect is primarily associated 
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with a direct influence on the maturation of the GIT in early life (Ontsouka et al., 2016). 
Therefore, understanding the progression of the GIT to a mature state, and determining 
what bioactive compounds in the colostrum have a predominant influence on this effect, 
are high priorities to minimize diarrhea and improve welfare among young dairy calves. 
However, studying early life maturation of the GIT can be challenging if this is done 
primarily through analysis and characterization of postmortem or surgical collections of 
GIT specimens. Such a challenge is more evident when repeated samplings over time on 
the same animals are desired to observe changes over time as well as to minimize animal 
variation. To overcome such challenges, we have previously proposed a novel technique 
by isolating RNA from fecal samples of newborn dairy calves with the aim of obtaining 
biological information on the GIT over time and using the same animals (Rosa et al., 
2018).  
Results from that study suggested that isolating RNA from fecal samples for 
subsequent quantitative reverse-transcription PCR analysis is a promising technique, 
where we observed biological adaptations of the young ruminant GIT over time to a mild 
diarrhea event, and these data were confirmed through blood biomarkers for 
inflammation and oxidative stress (Rosa et al., 2018). Although this technique is 
promising, several optimizations and validation steps are required to improve accuracy 
and robustness. For instance, the migration of PMN across the intestinal epithelium is a 
common pathological event of many mucosal inflammatory diseases (Brazil et al., 2010). 
Because the fecal RNA method described by Rosa et al. (2018) discriminated primarily 
against prokaryotic RNA (i.e., microbial RNA) but not immune cells, it is important to 
understand the potential influence immune cells such as PMN might have during fecal 
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RNA analysis. Additionally, the fecal RNA method is based on the premise that stool 
samples contain a considerable number of epithelial cells (Nishizawa et al., 2005). 
Consequently, evaluating the RNA enrichment from immune cells during fecal RNA 
isolation is essential to understand the reliability of this method. Therefore, the objective 
of this study was to evaluate the potential enrichment of RNA from PMN or GIT 
epithelial cells during RNA isolation from fecal samples of neonatal dairy calves. 
MATERIALS AND METHODS 
Experimental design 
 
The Institutional Animal Care and Use Committee of South Dakota State 
University approved all procedures for this study (protocol no. A3958–01). During a 
single sampling, fecal and blood samples were taken simultaneously from 8 neonatal 
Holstein calves less than 3 wk old (14.9 ± 5.5 d of age at sampling ± SD) with a mean 
fecal score [scale 1–4, 1: firm, well-formed (not hard); 4: liquid, splatters (Osorio et al., 
2012b)] of 2.0 ± 0.7 (mean ± SD) at sampling. 
RNA isolation, cDNA synthesis, primer design and evaluation, and quantitative PCR 
 
The fecal RNA isolation was conduct using the same protocol as explained in 
Rosa et al. (2018). Briefly, ~200 mg of fecal sample was used for RNA isolation using a 
Trizol (catalog no. 15596018, Ambion, Carlsbad, CA) based method along with the 
RNeasy Plus Mini Kit (Qiagen, catalog no. 74134), following the manufacturer’s 
instructions with some modifications. The RNA was eluted in 50 µL of RNase-free 
water, and the quantity for all fecal samples was 378.8 ± 192.3 ng/µL and purity 
(260/280 ratio) was 2.0 ± 0.1 determined via Nanodrop. In the case of PMN, the 
complete PMN isolation protocol is presented in the Supplemental File (https://doi.org/ 
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10.3168/jds.2018-16074), and this protocol has been previously described by Osorio et 
al. (2013). Briefly, 100 mL of blood was collected into evacuated tubes (10 mL, BD 
Vacutainer, Becton Dickinson, Franklin Lakes, NJ) containing solution A of trisodium 
citrate, citric acid, and dextrose. Samples were centrifuged at 600 × g for 30 min at 4°C. 
The plasma, buffy coat, and approximately one-third of the red blood cells were 
discarded. The remaining sample was purified through a series of washing and 
centrifugation steps using deionized water, 5 × PBS, and 1 × PBS. An aliquot (20 µL) 
obtained during the isolation process was used for PMN quantification and viability using 
a granulocyte primary antibody (CH138A, Veterinary Microbiology and Pathology, 
Washington State University, Pullman, WA) followed by a second antibody (Goat Anti-
Mouse IgM, Human ads-PE, Southern Biotech, Birmingham, AL). All samples harvested 
and used for analysis contained more than 80% PMN and had at least 90% viability. 
After PMN isolation, RNA was extracted using the Trizol-based method along with the 
RNeasy Plus Mini Kit. The RNA was eluted in 50 µL of RNase-free water, the quantity 
for all PMN samples was 55.6 ± 32.7 ng/µL, and the purity was 1.9 ± 0.1. The RNA 
integrity was assessed using the TapeStation (Agilent Technologies, Santa Clara, CA), 
and the final RNA integrity number was 5.0 ± 2.6. 
Details regarding primer sequences information and sources are presented in 
Supplemental Table 2.1 (https://doi .org/10.3168/jds.2018-16074). The cDNA synthesis 
and quantitative PCR were performed according to the protocol described by Rosa et al. 
(2018) with some modifications. Each cDNA was synthesized by reverse transcription 
using 500 and 100 ng of RNA for fecal and PMN samples, respectively. The quantitative 
PCR reaction was performed in a QuantStudio 6 Flex Real Time PCR System (Applied 
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Biosystems, Waltham, MA) in a MicroAmp Optical 384-well Reaction Plate (Applied 
Biosystems). Relative mRNA expression of each gene was calculated based on a 6-point 
relative standard curve plus the nontemplate control. Such a standard curve was 
composited from all samples including cDNA from fecal and PMN. The internal control 
genes (ICG) used in this experiment were golgin subfamily A, member 5 (GOLGA5), 
oxysterol-binding protein-like 2 (OSBPL2), single-strand-selective monofunctional 
uracil-DNA glycosylase 1 (SMUG1), β-2microglobulin (B2M), β-actin (ACTB), 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and ribosomal protein 9 (RPS9). 
Additionally, the ribosomal protein S15A (RPS15A) and peptidylprolyl isomerase A 
(PPIA) were evaluated as potential ICG, but they were deemed to have low stability 
across samples. Therefore, the geometric mean of the 7 ICG was used to normalize the 
expression of the target genes on both types of samples (i.e., fecal and PMN). The 
stability of the ICG was assessed using the geNorm software (Vandesompele et al., 
2002), with a favorable final pairwise variation of 0.19. The ribosomal protein S15A 
(RPS15A) and peptidylprolyl isomerase A (PPIA) were evaluated as potential ICG, but 
they were deemed to be unsuitable due to low stability across samples. Normalized gene 
expression data were log-transformed before statistical analysis. The target genes were 
selected based on their known specific association with either PMN or GIT epithelial 
cells. In the case of PMN, the genes selected were myeloperoxidase (MPO) and selectin-
L (SELL), which are well-documented genes specific for PMN (Bionaz and Loor, 2008, 
Moyes et al., 2009, Batistel et al., 2017), whereas aquaporin 3 (AQP3) (Ricanek et al., 
2015) and keratin 8 (KRT8) (Nishizawa et al., 2005) have been associated with epithelial 
enterocytes. 
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Statistical analysis 
 
Data were analyzed using the PROC MIXED procedure of SAS 9.4 (SAS 
Institute Inc., Cary, NC). The model included type (PMN or GIT) as fixed effect and calf 
as random. Statistical significance and tendencies were declared at P ≤ 0.05 and 0.05 ≤ P 
≤ 0.10, respectively. 
RESULTS AND DISCUSSION 
Keratins are the largest family of cellular intermediate filament proteins and are 
predominant in epithelial cells (Iyer et al., 2013), and among these, keratin 8 has been 
associated with mammary epithelial cells and small intestinal mucosa (Moll et al., 1982, 
Moll et al., 2008). In fact, the antibody against keratin 8 has been commonly used in 
ruminants for cell purification of mammary epithelial cells from total milk cells 
(Boutinaud et al., 2015). In contrast to epithelial cells, to the authors’ knowledge, the 
expression of keratin 8 has not been reported in immune cells, and specifically PMN. 
Accordingly, our results showed a substantially lower (P < 0.01) mRNA expression of 
KRT8 in PMN in comparison to fecal RNA (Table 2.1), which suggests that the fecal 
RNA samples contained a greater number of GIT epithelial cells. Interestingly, this is 
supported by KRT8 having the greatest mRNA abundance in fecal RNA (Table 2.2), in 
contrast to PMN, where SELL occupied the greatest mRNA abundance.  
The genes MPO and SELL encode the enzyme myeloperoxidase and the cell 
membrane L-selectin, respectively, and are essential for the normal cellular functions 
associated with PMN cells in bovine (Paape et al., 2003). Myeloperoxidase is required by 
PMN to produce reactive oxygen species responsible for the oxidative burst and 
consequently killing capacity of PMN, whereas L-selectin allows PMN to recognize sites 
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of infection or inflammation (Paape et al., 2003). Our results showed a lower (P = 0.01) 
mRNA expression of SELL and a lack of amplification of MPO in fecal RNA samples in 
comparison to the PMN samples (Table 2.1). Therefore, it is conceivable that the fecal 
RNA samples contained small amounts of PMN mRNA transcripts, which is in 
agreement with the greater expression of KRT8 in fecal RNA. Among the target genes in 
this study, MPO had a greater efficiency than normal (>3; Table 2.2), which could be 
associated with PCR amplification issues and indicates that the amplification, 
unrealistically, had more than a 1-fold increase during every cycle amplification. The 
authors associated this with the complete lack of amplification of MPO in fecal samples, 
which might have skewed the slope and consequently the amplification efficiency. 
Aquaporins are important cell transporters of water across biological membranes, and 
aquaglyceroporins, a subtype of aquaporins, are capable of transport water, glycerol, 
urea, and other small uncharged solutes across cell membranes (Rojek et al., 2008). 
Aquaporin 3 (encoded by AQP3) is an aquaglyceroporin with a wide tissue distribution 
including kidney, skin, esophagus, spleen, and small intestine among others (Rojek et al., 
2008). However, AQP3 is seldom reported to be expressed in PMN, and this 
aquaglyceroporin has been suggested to play a role in the uptake of microbes during 
phagocytosis (Marchini et al., 2003). In contrast to PMN, more data are available 
confirming the expression of AQP3 in enterocytes and, furthermore, describing a role for 
AQP3 during bacterial-induced diarrhea events in humans (Ricanek et al., 2015) and rats 
(Zhao et al., 2014). We recently demonstrated the amplification of AQP3 in fecal RNA in 
neonatal dairy calves, which also demonstrated a downregulation during a mild diarrhea 
event (Rosa et al., 2018). Interestingly, the current results demonstrate a trend (P = 0.06) 
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for a greater expression of AQP3 in PMN in comparison to fecal RNA. Due to the lack of 
functional data on AQP3 in PMN, the latter effect remains unclear; however, the 
expression of other aquaglyceroporins such as AQP9 have been reported in peripheral 
leukocytes (Ishibashi et al., 1998). 
Taking these data together, we observed a contrasting gene expression profile 
between PMN and fecal RNA; whereas the greater mRNA expression of SELL in PMN 
was expected, the greater mRNA expression of KRT8 in fecal RNA suggests that a 
considerable amount of RNA originated from epithelial cells in fecal RNA. These data 
provide new evidence on the reliability of the fecal RNA method; however, the data are 
not conclusive and further research needs to be done to improve the accuracy and 
robustness of this method while determining its limitations. 
CONCLUSIONS 
 
The data presented here are nuances in the refinement of the fecal RNA method to 
study biological adaptations of the GIT of neonatal dairy calves through analysis of 
transcriptional alterations. Our findings suggest that under nondiarrheic conditions RNA 
isolated from stool samples of neonatal dairy calves will have a considerable number of 
GIT epithelial cells, which confirms the reliability of this method under these conditions. 
However, further research needs to be done to determine if the same effects are observed 
during diarrhea or throughout the preweaning period of dairy calves. 
  
28 
 
Acknowledgments 
 
This work was supported by the South Dakota Agricultural Experimental Station 
under project No. SD00H612-16. We gratefully acknowledge the help from the staff of 
South Dakota State University Dairy Research and Teaching Facility for animal care and 
handling.  
29 
 
  
Table 2.1 Messenger RNA expression for specific gene markers for PMNL and GIT 
epithelial cells in non-diarrheic neonatal dairy calves. 
Gene 
Sample Type 
SEM1 P-value Fecal PMNL 
KRT8 2.43 -9.08 0.52 < 0.01 
SELL -5.58 -2.57 0.70    0.01 
MPO2 -- -0.36 2.31 -- 
AQP3 -4.25 -2.45 0.70    0.06 
1Largest standard error of the mean. 
2Standard deviation for MPO in PMNL.  
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Table 2.2 Slope, coefficient of determination of the standard curve (R2), efficiency of 
amplification, and median cycle threshold (Ct) of quantitative reverse transcription 
PCR. 
Gene Slope1 R2 E2 Ct3 mRNA abundance (%)4 
All samples 
   SELL -3.459 0.98 1.95 21.90 99.38 
   AQP3 -3.171 0.99 2.07 29.93 0.48 
   KRT8 -2.902 0.99 2.21 32.41 0.13 
   MPO -2.076 0.95 3.03 32.19 0.00 
PMNL samples 
   SELL -3.459 0.98 1.95 21.46 99.55 
   AQP3 -3.171 0.99 2.07 29.05 0.44 
   KRT8 -2.902 0.99 2.21 33.12 0.01 
   MPO -2.076 0.95 3.03 31.87 0.00 
Fecal samples 
   KRT8 -2.902 0.99 2.21 27.03 75.15 
   SELL -3.459 0.98 1.95 29.91 24.74 
   AQP3 -3.171 0.99 2.07 35.60 0.10 
   MPO -2.076 0.95 3.03 N/A 0.00 
1Slope of the 6-point standard curve. 
2Efficiency of amplification [E=10(-1/slope)]. 
3Ct = median cycle threshold which is defined as the number of cycles required for the 
fluorescent signal to cross the threshold (i. e. exceed background level), and the amount of 
target nucleic acid in the sample is inversely correlated to Ct cycles (i. e., the greater the 
amount of target nucleic acid the lower the Ct cycles will be required). 
4mRNA abundance is calculated as a percentage of (1/E∆Ct) specific gene in the sum (1/E∆Ct) 
all genes.  
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Supplemental Table 2.1 Features of used primers for qPCR analysis. Hybridization 
position, sequence, and amplicon size of primers for Bos taurus used to analyze gene 
expression. 
Gene 
Symbol 
Primer1 Primers (5’-3’) bp2 
Source 
GOLGA5 F.1370 GAGCTACAGCAGCAAGTCAAAGTG 103 Moyes et al. (2009) 
 R.1472 CTTTAGACTGGAGTATTCGAGTAGCTTT
T 
  
OSBPL2 F.198 TGCCGTCACAGGCTTTGAC 100 Moyes et al. (2009) 
 R.297 CCATTACTTGCTGGTGTCCACAT   
SMUG1 F.258 CAGCTACGTGACCCGCTACTG 117 Moyes et al. (2009) 
 R.374 CGGACTACACTCACTTCACCAAAG   
GAPDH F.908 TTGTCTCCTGCGACTTCAACA 103 Kadegowda et al. (2009) 
 R.1010 TCGTACCAGGAAATGAGCTTGAC   
ACTB F.624 GCGTGGCTACAGCTTCACC 54 Kadegowda et al. (2009) 
 R.677 TTGATGTCACGGACGATTTC   
B2M F.99 TCCAGCGTCCTCCAAAGATT 86 Kadegowda et al. (2009) 
 R.184 CCCATACACATAGCAGTTCAGGTAA   
RPS9 F.192 CCTCGACCAAGAGCTGAAG 54 Bionaz and Loor (2007) 
 R.254 CCTCCAGACCTCACGTTTGTTC   
RPS15A F.405 GCAGCTTATGAGCAAGGTCGT 151 Bionaz and Loor (2007) 
 R.555 GCTCATCAGCAGATAGCGCTT   
PPIA F.125 TCTGAGCACTGGAGAGAAAGGATTTG 88 Rosa et al. (2018) 
 R.212 GAAGTCACCACCCTGGCACATA   
AQP3 F.398 GGGTTGTATTACGATGCGATCTG 81 Rosa et al. (2018) 
 R.478 AAAGATGCCAGCTGTGCCATTG   
MPO F.1311 AGCCATGGTCCAGATCATCAC 105 Batistel et al. (2017) 
 R.1415 ACCGAGTCGTTGTAGGAGCAGTA   
SELL F.588 CTCTGCTACACAGCTTCTTGTAAACC  104 Li et al. (2016) 
 R.691 CCGTAGTACCCCAAATCACAGTT   
KRT8 F. 1352 AGTGGCTACGCAGGTGGACT 181 Boutinaud et al. (2008) 
 R. 1532 CCGCAAGAGCCTTTCACTTG   
1Primer direction (F – forward; R – reverse) and hybridization on the sequence. 
2Amplicon size in base pair (bp). 
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CHAPTER 3. COMPARATIVE GENE EXPRESSION ANALYSIS OF 
EPITHELIAL CELL MARKERS ACROSS GASTROINTESTINAL TISSUES 
AND FECAL RNA ISOLATED FROM DAIRY CALVES 
 
ABSTRACT 
 
Our objective in this study was to compare the transcription of gene markers for 
gastrointestinal tract (GIT) epithelial cells, fatty acid binding protein 2 (FABP2) and 
cytokeratin 8 (KRT8), and tight junction complex genes (TJP1, CLDN1, CLDN4) in fecal 
RNA against several GIT sections in dairy calves. Postmortem samples were collected 
from ruminal epithelium, cecum, large intestine, duodenum, jejunum, ileum, and feces 
from six healthy male Jersey calves (5 wk of age) for total RNA isolation. Normalized 
gene expression data were log-transformed prior to statistical analysis using the Proc 
Mixed of SAS. The expression of FABP2 was greater (P < 0.01) in the duodenum tissue 
than in the GIT section associated with fermentation (i.e., rumen, large intestine, and 
cecum). Within the small intestine, the mRNA expression of FABP2 was greater (P = 
0.01) in duodenum than in jejunum, but not different than ileum. In fecal RNA, the 
FABP2 expression was greater (P ≤ 0.03) than in the GIT section related to fermentation. 
However, FABP2 was similar (P = 0.3) between fecal RNA and ileum. The expression of 
KRT8 was greater (P ≤ 0.02) in cecum and large intestine than in rumen and jejunum. 
Among the small intestine sections KRT8 was greater (P = 0.03) expressed in duodenum 
than in jejunum. The fecal RNA had greater (P ≤ 0.02) expression of KRT8 than jejunum 
and ileum. In contrast, the KRT8 expression in fecal was not different from the transcripts 
observed in cecum and large intestine. Fecal RNA showed the greatest expression of the 
33 
 
3 tight junctions proteins measured (P < 0.01) compared with the GIT tissues. However, 
the expression of CLDN1 was higher in the ruminal tissue than in the fecal RNA (P = 
0.03). The tight junctions TJP1, CLDN1, and CLDN4 were ubiquitously expressed (P ≥ 
0.5) through duodenum, jejunum, and ileum. Since the transcription of the genes specific 
for GIT epithelial cells were significantly observed in the RNA isolated from feces, as 
well as the genes encoding the tight junctions proteins, these preliminary data further 
confirm that fecal RNA has a potential to be used as a tool to evaluate molecular 
adaptations in the GIT of dairy calves. 
Keywords: dairy calves; feces; RNA; intestinal health 
INTRODUCTION 
 
The gastrointestinal tract (GIT) or “gut” functionality is crucial for optimal animal 
performance, including growth and milk yield in dairy cattle.  Gut health has been 
associated with animal welfare involving physiological aspects such as nutrient 
absorption and energy metabolism, barrier function via mucosal secretion, interaction 
with the gut microbiome (Kogut and Arsenault, 2016). The GIT has multiple functions 
beyond the digestion and absorption of nutrients, for instance, regulation of the 
physiological homeostasis that protects the host against exogenous stressors such as 
harmful pathogens present in the lumen (Leaphart and Tepas, 2007). The GIT consists of 
a symbiotic system which at equilibrium, involves bacteria-host interaction that regulates 
intestinal barrier by a network of immune mechanisms including mucosal, pro- and anti-
inflammatory response (Hooper and Macpherson, 2010). Together, all these mechanisms 
in the intestinal epithelium are the key to maintain the GIT equilibrium state, while 
alterations in the gut barrier such as mucus degradation, and increased intestinal 
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permeability can cause pro-inflammatory reactions and translocation of pathogens, 
leading to gastrointestinal inflammatory conditions and possibly systemic inflammation 
(Bischoff et al., 2014). Additionally, the GIT of neonatal animals undergoes 
morphological and functional adaptation after birth, which is associated with overall 
health. Regarding dairy calves, the neonatal stage is the period of high susceptibility to 
infections, including pathogens that target the mucosal epithelium of the small intestine 
(Malmuthuge et al., 2019). Therefore, understanding the interactions between these 
diverse physiological features by gut health and how they affect the host can potentially 
regulate animal production. Several experimental methods, including histology and 
immunochemical staining, are used to investigate GIT physiology and pathology. 
However, tissue preparation for histology requires invasive techniques, such as biopsy or 
euthanasia (Bischoff et al., 2014). Besides the histological assays, molecular-based tools 
(i.e., PCR and next-generation sequencing) have been used to investigate the biological 
mechanisms underlying the gastrointestinal epithelium and barrier function early in life 
of dairy calves (Liang et al., 2016, Malmuthuge and Guan, 2017), however the initial 
acquire of samples relies on invasive method of tissue collections. A noninvasive method, 
based on fecal RNA, to study the GIT in neonatal dairy calves through the isolation of 
host-RNA from fecal samples for quantitative reverse-transcription PCR was described 
by (Rosa et al., 2018).  This study demonstrated that inflammatory transcripts present in 
fecal RNA were associated with blood biomarkers of inflammation during the neonatal 
stage of dairy calves undergoing a mild-diarrhea condition. Further improvements of this 
method quantified genes in the feces of dairy calves associated with transcripts of 
epithelial cells origin rather than from immune cells (Rosa and Osorio, 2019a). Taking 
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together, these two approaches demonstrated that fecal RNA has the potential to be used 
as a non-invasive tool to provide valuable information on GIT biological adaptations 
during the preweaning period of dairy calves. Currently, no biomarkers have been 
described as tools to evaluate GIT inflammatory condition or intestinal barrier function 
through a non-invasive method such as feces analysis in dairy calves. Therefore, the 
objective of this study was to evaluate well-known epithelial cell markers [i.e., fatty acid 
binding protein 2 (FABP2); cytokeratin 8 [KRT8]), as well as regulatory proteins of the 
intestinal permeability (i.e., tight junction proteins complex) across gastrointestinal 
tissues and in the feces isolated from preweaned dairy calves.  
MATERIALS AND METHODS 
 
Animals and experimental design 
 
All the protocols for this study (protocol no. 4747) were approved by the 
Institutional Animal Care and Use Committee. Details for the original experimental 
design have been published previously (Rosa et al., 2018). Briefly, 8 healthy male Jersey 
neonatal calves were enrolled in a completely randomized design from birth to 5 wk of 
age (i.e., preweaned period). Calves were housed in individual pens and fed twice daily 
with pasteurized whole cow milk. Calves had ad libitum access to water and a starter 
grain throughout the experiment.  
Euthanasia and tissue collection 
 
 At the end of the trial, 6 preweaned calves (5 wk old) were euthanized by 
rapid intravenous injection of a barbiturate (Somnasol euthanasia solution, Henry Schein) 
to harvest gastrointestinal tissues (i.e., ruminal tissue, duodenum, jejunum, ileum, large 
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intestine, and cecum) for gene expression analysis. Tissues were harvested using sterile 
scalpel and forceps and were immediately cleaned with RNase decontamination solution 
(RNaseZap®, AM9780, Thermo Fisher Scientific), quickly blotted with sterile gauze to 
remove residual blood and snap-frozen in liquid nitrogen. Additionally, prior to the 
euthanasia procedure, a fresh fecal sample was collected from each calf through rectum 
stimulation into a 2 mL cryogenic vial (Corning®, Cat. # 430488), and immediately 
snap-frozen in liquid nitrogen. All samples were then stored at -80°C until RNA 
extraction. 
RNA extraction and real-time quantitative PCR  
 
The fecal RNA isolation was conduct using the same protocol, as described in 
Rosa et al. (2018). Briefly, ~200 mg of fecal sample was utilized for RNA isolation using 
a Trizol (Ambion, Cat. No. 15596018) based method along with the RNeasy Plus Mini 
Kit (Qiagen, Cat. No. 74134), following the manufacturer’s instructions with some 
modifications. The overall RNA quantity for all fecal samples was 428.38 ± 37.92 ng/µL, 
and purity (260/280 ratio) was 1.97 ± 0.08 determined via Nanodrop. For the rumen and 
gastrointestinal samples, 100mg of tissue was used for RNA isolation. And the RNA 
quantity and purity determined via nanodrop was 1,868.53 ± 61.23 ng/µL and 2.09 ± 
0.02, respectively. 
Details regarding primer sequences information and sources are presented in 
Tables 3.1 and 3.2. The complementary DNA (cDNA) synthesis and quantitative PCR 
were performed according to the protocol described by Rosa et al. (2018) with some 
modifications. Each cDNA was synthesized by reverse transcription using 500 ng and 
100 ng of RNA for fecal and GIT tissues, respectively. The cDNA was then diluted 1:3 
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(vol:vol) with DNase/RNase-free water. The qPCR reaction was performed in a 
QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems, USA) in a 
MicroAmp® Optical 384-well Reaction Plate (Applied Biosystems, USA). Relative 
mRNA expression of each gene was calculated based on a six-point relative standard 
curve plus the non-template control, which was composed of all cDNA samples from 
fecal and GIT tissues. The internal control genes (ICG) used in this experiment were β-2-
microglobulin (B2M), β-actin (ACTB), glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), ribosomal protein 9 (RPS9), ribosomal protein S15A (RPS15A), and 
peptidylprolyl isomerase A (PPIA). The stability of the ICG was assessed using the 
geNorm software (Vandesompele et al., 2002), with a favorable final pairwise variation 
of 0.21. Therefore, the geometric mean of the six ICGs was used to normalize the 
expression of the target genes. The target genes evaluated in this study were the intestinal 
epithelial cell marker FABP2, the keratin epithelial cell marker (KRT8), the tight junction 
protein ZO-1 (TJP1), and the claudins 1, and 4, members of the tight junction complex 
(CLDN1 and CLDN4, respectively).  
 
Statistical analysis 
 
Data were analyzed using the PROC MIXED procedure of SAS 9.4 (SAS Institute, 
Inc., Cary, NC, USA). The model included type of sample (fecal or GIT tissues) as a fixed 
effect and calf as random. Statistical significance and tendencies were declared at P ≤ 0.05 
and 0.05 ≤ P ≤ 0.10, respectively.  
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RESULTS AND DISCUSSION 
 
The GIT is considered to be the largest organ to play a key role in the immune 
system, encompassing an intensive communication between the host and the gut 
microbiome and digesta. The GIT represents a structural barrier, including vascular 
endothelium, the epithelial cell lining, and the mucus layer, as well as, a functional 
barrier, including immune molecules (i.e., immune cells,  IgA secretion), antimicrobial 
peptides secretion, inflammatory mediators, and cytokines production (Vighi et al., 
2008). The epithelial layer of the GIT presents a physical barrier that protects againts 
exogenous pathogens and toxins entering the host. And such an epithelial layer consists 
of cells connected by tight junction complexes. The tight junction protein complex is an 
intercellular junction located in the apical membrane of the epithelial cells that connected 
each cell, excluding the influx of pathogens and large molecules through the paracellular 
pathway while allowing the diffusion of ions, water, and small molecules (Wells et al., 
2017). Tight junctions proteins include transmembrane proteins such as occludins and 
claudins and intracellular proteins such as  zonula occludens (ZO) proteins. In the 
intestinal epithelium, the tight junctions proteins have been reported to decrease the 
paracellular permeability (Angelow and Yu, 2009). Then, it is conceivable that such tight 
junction proteins are essential during the development of gut-related diseases such as 
celiac disease due to hyperpermeability of the intestinal epithelium (Bischoff et al., 
2014). Thus, tight junctions proteins are directly associated with intestinal epithelium 
permeability (Van Itallie et al., 2009, Yu et al., 2014). In this study, we observed that the 
expression of TJP1 is similar (P > 0.05) among the small intestine sections. TJP1 
expression did not differ between the sections of the small intestine when compared to 
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the cecum and large intestine (Figure 3.1). The TJP1 expression was similar (P = 0.12) 
between the duodenum and ruminal tissue. However, the fecal samples had the greatest 
(P < 0.01) expression of the TJP1 when compared with all the other small intestine 
sections, cecum, large intestine, or ruminal tissue (Figure 3.1). The ruminal tissue had 
greater (P ≤ 0.04) expression of the TJP1 than cecum, large intestine,  jejunum, and 
ileum. The claudins gene expression (CLDN1 and CLDN4) were similarly expressed (P > 
0.05) in the duodenum, jejunum, or ileum (Figure 3.1). The CLDN1 expression was 
greater (P = 0.03) in the ruminal tissue than in the fecal samples; however, the CLDN4 
expression was greater (P < 0.01) in the fecal samples rather than in the ruminal tissue. In 
fecal and ruminal samples, both CLDN1 and CLDN4 expression was greater (P ≤ 0.02) 
when compared to cecum, large intestine, and the small intestine sections (Figure 3.1). 
These findings are similar with other reports, where the expression of CLDN1 did not 
differ among gastrointestinal regions of dairy calves during weaning transition from milk 
to solid feed (Malmuthuge et al., 2013), as well as in dairy calves of 4 wk old (Walker et 
al., 2015). Also, studies conducted in mice demonstrated that among the claudins (from 
claudin-1 to- 19), the CLDN1, CLDN4, CLDN5, CLDN9, and CLDN10  were the lowest 
expressed in the gastrointestinal regions (i.e., duodenum, jejunum, ileum, cecum, and 
colon). Additionally, this study showed that there was no difference in the expression of 
those claudins throughout the gut regions (Holmes et al., 2006). Several studies 
demonstrated that tight junction complexes could be disrupted in the GIT due to 
pathogenic infections either in humans, piglets, or calves, reducing the barrier function of 
the epithelium  (Guttman and Finlay, 2009, Jacobi et al., 2013, Walker et al., 2015). A 
study conducted in neonatal lambs demonstrated that CLDN1 and CLDN4 expression in 
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the ileum was altered due to early weaning (Li et al., 2018), which can be considered a 
stressor triggering inflammation and intestinal barrier dysfunction. Inflammatory 
responses including the production of pro-inflammatory cytokines (i.e., IFN-, TNF-, 
and IL-1) can cause a dysregulation of tight junction proteins by altering their 
expression, leading to increased paracellular permeability (Adams et al., 1993, Ma et al., 
2004, Al-Sadi and Ma, 2007). The tight junction proteins, TJP1 and CLDN,1 were 
expressed at higher levels in the jejunum mucosal of heated stressed cows than control 
(i.e., healthy) cows, which can be related with the relationship between inflammation and 
GIT permeability (Koch et al. 2019). In the current study, the time of tissue collection 
used for the RNA isolation was during the pre-weaning phase, when the dairy calves 
were under the transition of being weaned from milk 1× d to an exclusively solid feed 
diet, which is a stressor for dairy calves (Klotz and Heitmann, 2006). 
The high tight junction expression in the ruminal tissue might be associated with 
the morphological structure of the ruminal epithelium in contrast to the intestinal 
epithelium. The rumen epithelium consists of stratified cells with leaf-like papillae that 
increase the absorptive surface area. It is well established that the transport of nutrients 
across the rumen epithelium is mediated by a gradient concentration difference (Sehested 
et al., 1999, Shen et al., 2004). This rumen epithelium forms a permeability barrier 
including tight junction proteins facing the ruminal lumen at the apical membrane of the 
stratum granulosum. In contrast to the multilayered stratified squamous epithelium found in 
the rumen, the small intestine, cecum, and large intestine consist of a simple columnar 
epithelium that encompasses mucus-secreting cells resulting in a dense mucus layer (Steele et 
al., 2016a). This mucus layer results in an extra layer of protection to the host within GIT 
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regions, which does occur in the rumen (Graham and Simmons, 2005). The high abundance 
of the tight junctions related genes (Table 3.3) within the ruminal samples can be attributed to 
the morphological and physiological difference between the rumen and small intestine 
epithelium. However, the high level of TJP1, CLDN1, and CLDN4 mRNA expression in the 
fecal of preweaned calves observed in the current study` might be associated with epithelium 
permeability of the rumen and lower gut. Moreover, these findings can be related with the 
greater expression of inflammatory-related genes TNFA, NFKB1, IL1B, and TLR4 in the 
feces of dairy calves at 4 and 5wk of age (Rosa et al. 2018), In that study, the calves were not 
undergoing diarrhea (i.e., formed solid feces) during the time of the euthanasia and tissue 
collection. 
Keratins are the largest family of cellular intermediate filament proteins and are 
predominant in epithelial cells (Iyer et al., 2013), and among the keratin family, keratin 8 
has been associated with mammary epithelial cells and small intestinal mucosa (Moll et 
al., 1982, Moll et al., 2008). Anti-keratin 8 antibody has been commonly used in 
ruminants for cell purification of mammary epithelial cells from total milk cells 
(Boutinaud et al., 2015). Keratin 8 has been used to measure exfoliated epithelial cells in 
the feces of preterm infants with the aim to use fecal samples instead of invasive methods 
to investigate GIT physiology (Kaeffer et al. 2007). Additionally, KRT8 expression was 
used as a marker for intestinal epithelial cells in dairy cows (Koch et al., 2019). In the 
current study, KRT8 expression was similar between the duodenum and fecal samples (P 
= 0.18), as well as, KRT8 was similarly expressed in the cecum and large intestine when 
compared to the feces mRNA (P = 0.30). However, the expression of KRT8 was greater 
(P ≤ 0.02) in feces than in the jejunum and ileum tissues (Figure 3.2).  
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Fatty acid binding proteins (FABP), which are small cytosolic proteins found in 
enterocytes of both the small and large intestine are involved in the transportation and in 
the metabolism of long-chain fatty acids, and such proteins have been used as a potential 
marker for intestinal epithelial cells, since they are primarily produced by epithelial cells 
of the small intestine and their release in blood circulation depends upon disease state of 
the GIT (Funaoka et al., 2010, Bottasso Arias et al., 2015). Among the nine FABP 
identified, the mRNA expression of FABP2 is highly expressed in the small intestine, and 
it has been identified as a specific marker for the relative amount of epithelium in humans 
(Levy et al., 2001). In livestock production, the FABP2 expression in the small intestine 
of pigs was associated with intestinal permeability (Schroyen et al., 2012), as well as, the 
loss of enterocytes was associated with a decrease in the FABP2 expression in the jejunal 
mucosa of broiler chickens (Chen et al., 2015). In the present study (Figure 3.2), the 
similar expression of FABP2 in the feces of calves compared to the expression in the 
jejunum (P = 0.58) and ileum (P = 0.36), suggests that FABP2 gene can be used as a 
biomarker of enterocytes when analyzed in feces. 
Taken together, our findings demonstrated that there might be a difference in the 
level of tight junction proteins between the rumen epithelium and intestinal epithelium of 
dairy calves, and that can be attributed to the differential cell layers structure of the 
epithelia. Regarding the specific epithelial cell markers, the low abundance of KRT8 and 
FABP2 mRNA within ruminal samples (Table 3.3) is an indication that these markers are 
highly specific to intestinal epithelial cells in ruminants, as previously demonstrated in 
humans (Wiercinska-Drapalo et al., 2008, Gajda and Storch, 2015). Thus, this is in 
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accordance with the greatest mRNA abundance of the FABP2 within the small intestine 
samples evaluated (Table 3.3).  
CONCLUSION 
 
The similar mRNA expression of FABP2 and KRT8, known intestinal tissue 
biomarkers, between fecal RNA and the lower GIT tissues indicates that to some extent, 
the fecal RNA is a suitable proxy for lower GIT gene expression. The greater expression 
of tight junctions genes (CLDN1, CLDN4, and TJP1) observed in the fecal transcripts in 
comparison to GIT tissues was unexpected and warranted further exploration of this 
effect in future research on fecal RNA. Based on the paramount importance of 
gastrointestinal functionality to animal health and performance, having identified 
biomarkers of GIT function and permeability in fecal RNA provide further evidence that 
this technique can be a valuable asset to livestock research in gut health in the future. 
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Table 3.1 Gene symbol, hybridization position, sequence, and amplicon size of primers 
for Bos Taurus used to analyze gene expression. 
Gene symbol Primers1 Primers (5’ – 3’) bp2 Source 
GAPDH F.908 
R. 1010 
TTGTCTCCTGCGACTTCAACA 
TCGTACCAGGAAATGAGCTTGAC 
103 (Kadegowda et 
al., 2009) 
ACTB F.624 
R.677 
GCGTGGCTACAGCTTCACC 
TTGATGTCACGGACGATTTC 
54 (Kadegowda et 
al., 2009) 
B2M F.99 
R.184 
TCCAGCGTCCTCCAAAGATT 
CCCATACACATAGCAGTTCAGGTAA 
86 (Kadegowda et 
al., 2009) 
RPS9 F.192 
R.254 
CCTCGACCAAGAGCTGAAG 
CCTCCAGACCTCACGTTTGTTC 
54 (Kadegowda et 
al., 2009) 
RPS15A F.405 
R.555 
GCAGCTTATGAGCAAGGTCGT 
GCTCATCAGCAGATAGCGCTT 
151 (Bionaz and Loor, 
2007) 
PPIA F.125 
R.212 
TCTGAGCACTGGAGAGAAAGGATTTG 
GAAGTCACCACCCTGGCACATA 
88 (Rosa et al., 2018) 
KRT8 F.1352 
R.1532 
AGTGGCTACGCAGGTGGACT 
CCGCAAGAGCCTTTCACTTG 
181 (Boutinaud et al., 
2008) 
FABP2 F.371 
R.471 
GTGGCGAGATGGTCCAGACT 
TCTGTGTTCTGGGCAATGCTC 
101 This manuscript 
CLDN1 F.480 
R.579 
GGCATCCTGCTGGGACTAATAG 
CAGCCATCCGCATCTTCTGT 
100 (Minuti et al., 
2015) 
CLDN4 F.695 
R.797 
CCCCAGCCAGCAACTACGT 
TCACAGATTGCAGTGAGCTCAGT 
103 (Minuti et al., 
2015) 
TJP1 F.3748 
R.3854 
GCACATAGGATCCCTGAACCA 
TGCTTCCGGTAGTACTCCTCATC 
107 (Minuti et al., 
2015) 
1Primer direction (F – forward; R – reverse) and hybridization on the sequence. 
2Amplicon size in base pair (bp). 
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Table 3.2 Sequencing results obtained from qPCR of Bos Taurus specific primers. 
Gene Sequence 
FABP2 CATAGGTGTCACCAGATGATTTCCAAAAGGACGAGCACTGTTCCTGGAGCATCCCAAT
CACACAGATTTTTTGGGGCTCCTTGGTGGCCCTGTTTTGGTGAAGCTGAAGTATTCATT
GATGCTGATGCCTGACAAAGAGGTATGGGTTAACTGGGATTGTTTGGGAAGGAAATCG
GTTGGC 
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Table 3.3 Slope, efficiency (E) of amplification, coefficient of determination of the 
standard curve (R2), median cycle threshold (Ct) of quantitative reverse-transcription PCR, 
and relative mRNA abundance. 
Gene Slope1 E2 R3 Median Ct4 mRNA abundance %5 
All Samples      
FABP2 -3.006 2.15 0.99 21.84 66.54 
KRT8 -2.888 2.22 0.98 22.77 18.45 
CLDN1 -3.290 2.01 0.99 25.30 1.79 
CLDN4 -2.920 2.20 0.98 24.09 3.39 
TJP1 -3.258 2.03 0.99 22.77 9.83 
Fecal samples      
FABP2 -3.006 2.15 0.99 26.02 21.70 
KRT8 -2.888 2.22 0.98 26.37 8.83 
CLDN1 -3.290 2.01 0.99 29.23 1.23 
CLDN4 -2.920 2.20 0.98 23.77 63.13 
TJP1 -3.258 2.03 0.99 27.11 5.11 
Small Intestine samples      
FABP2 -3.006 2.15 0.99 17.86 95.25 
KRT8 -2.888 2.22 0.98 22.18 2.07 
CLDN1 -3.290 2.01 0.99 24.92 0.39 
CLDN4 -2.920 2.20 0.98 24.70 0.28 
TJP1 -3.258 2.03 0.99 22.89 2.00 
Rumen samples      
FABP2 -3.006 2.15 0.99 32.76 0.01 
KRT8 -2.888 2.22 0.98 25.05 1.32 
CLDN1 -3.290 2.01 0.99 21.12 37.24 
CLDN4 -2.920 2.20 0.98 21.05 40.89 
TJP1 -3.258 2.03 0.99 22.01 20.54 
1Slope of the 6-point standard curve. 
2Efficiency of amplification [E=10(-1/slope)]. 
3 coefficient of determination of the standard curve (R2) 
4Ct = median cycle threshold which is defined as the number of cycles required for the 
fluorescent signal to cross the threshold (i. e. exceed background level), and the 
amount of target nucleic acid in the sample is inversely correlated to Ct cycles (i. e., 
the greater the amount of target nucleic acid the lower the Ct cycles will be required). 
5mRNA abundance is calculated as a percentage of (1/E∆Ct) specific gene in the sum 
(1/E∆Ct) all genes.  
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Figure 3.1 Tight junction protein ZO-1 (TJP1), claudin 1 (CLDN1), and claudin 4 
(CLDN4) relative mRNA expression (log2 scale) in rumen, gastrointestinal tract tissues, 
and in total fecal RNA isolated from Jersey calves with 5 wk of age. 
a,b,c,dmeans without a common superscript differ (P ≤ 0.05). 
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Figure 3.2 Fatty acid binding protein 2 (FABP2) and keratin 8 (KRT8) relative mRNA 
expression (log2 scale) in rumen, gastrointestinal tract tissues, and in total fecal RNA 
isolated from Jersey calves with 5 wk of age. 
a,b,c,dmeans without a common superscript differ (P ≤ 0.05). 
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CHAPTER 4. EARLY LIFE FECAL MICROBIOTA TRANSPLANTATION 
AFFECTS GROWTH PERFORMANCE, CALF SYSTEMIC, AND 
POLYMORPHONUCLEAR LEUKOCYTES MRNA INDICATORS OF 
INFLAMMATION AND LIVER FUNCTION IN NEONATAL DAIRY CALVES 
 
ABSTRACT 
 
The objective of this study was to evaluate the effects of early life fecal microbial 
transplantation (FMT) on health and performance of neonatal dairy calves. The adult donor 
was selected based on health and production records as well as fecal samples testing 
negative for infectious pathogens. Sixteen healthy newborn Holstein calves (n=8/trt) were 
used in a randomized complete block design and housed in individual hutches from birth to 
7 wk of age. Calves were fed 2.8 L/d of antibiotic-free milk replacer 2×/d during wk 1 to 5, 
1×/d on wk 6, and weaned at wk 7. Antibiotic-free starter and water were fed ad libitum. 
Calves were assigned to either a baseline nutritional program (CON) or 1×/d inoculations 
with 25 g of fecal donor material (FMT) mixed in the milk replacer from 8 to 12 d of age. 
Blood samples were collected weekly for immunometabolic profiling and 
polymorphonuclear leukocytes (PMNL) isolation for gene expression analysis. Data were 
analyzed using the MIXED procedure of SAS. There was a trend (P = 0.09) for greater 
body weight (50.8 vs 52.7 kg±0.7) in FMT calves.  A TRT × Wk (P = 0.02) interaction was 
observed in haptoglobin, that was reflected in a positive quadratic effect (P = 0.04) in FMT 
calves but not in CON. A trend for a TRT × Wk (P = 0.06) interaction was observed in the 
liver function biomarker paraoxonase, which resulted in greater (P < 0.01) paraoxonase in 
FMT calves than CON at 3 wk of age. In albumin, the trend (P = 0.14) in TRT × Wk 
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resulted in a trend (P ≤ 0.09) for lower albumin in FMT calves than CON at wk 1 and 2, 
but albumin in FMT calves reached a similar concentration than CON by wk 3. A trend (P 
= 0.07) for a TRT × Wk was observed in IL1B, which resulted in a contrasting positive 
quadratic effect (P = 0.07) over time in FMT, while a linear increase (P = 0.07) was 
observed in CON. The TRT × Wk (P = 0.09) in NFKB1 mRNA expression in  PMNL was 
associated with an upregulation (P = 0.03) in FMT calves than CON at wk 1 of age. These 
results suggest that early life FMT in neonatal calves has positive effects in their neonatal 
stage not only on growth performance but also in mediating the inflammatory response and 
liver function.  
Keywords: calves, fecal inoculation, microbiota 
INTRODUCTION 
 
The paradigm that the fetus develops within a sterile environment, born bacteria-
free, and its first contact with bacteria only occurs after birth has been fundamentally 
challenged (Elgin et al., 2016); the presence of microbiota was detected in newborn human 
meconium (Jiménez et al., 2008), amniotic fluid and in the umbilical cord blood (Jimenez 
et al., 2005), as well as in placental membrane (Aagaard et al., 2014, Collado et al., 2016). 
Similar to humans, bacteria were detected in newborn calf meconium (Mayer et al., 2012) 
and bovine uterus (Karstrup et al., 2017). Early life neonatal gut colonization can be 
affected by prenatal factors including maternal microbiota, delivery mode, and by postnatal 
factors such as colostrum intake, immune defense mechanisms, microbes adhesion, and 
survival mechanisms as well as host luminal pH, diet, and antibiotic treatment 
(Malmuthuge and Guan, 2017). Factors affecting the early life microbiome colonization of 
the neonate gut can fundamentally challenge neonates and put them at risk for immune and 
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metabolic disorders. It has been demonstrated that cesarean-born infants are deprived of the 
vaginal microbiota inoculation as they pass through the birth canal and this can predisposed 
them to long-term health consequences (Dominguez-Bello et al., 2016). Similarly, other 
maternal microbiota in colostrum and milk have invaluable benefits in the health and 
immunity of neonates across mammalian species.  
In addition to the microbial colonization after birth, there is a gradual maturation of 
gastrointestinal epithelial cells (GEC) that can be influenced by diet, length of gestation, 
and antibiotic usage. The latter has been closely associated with a fundamental disruption 
of the normal intestinal flora (i.e., dysbiosis), and consequently, linked with diseases in 
both humans and animals (Francino, 2015). Therefore, early life gut colonization is a 
crucial period for the adequate development of the neonate gut and immune system 
(Hansen et al., 2012) and may have long-term health effects. Manipulation of gut 
microbiota by feeding either probiotics or prebiotics has been studied in livestock animals 
as strategies to improve production and health (Herfel et al., 2011, Vieira et al., 2013).  
Enteric infections are the major causes of calf death during the first 4 wk of life 
(Cho and Yoon, 2014). Developing methods to minimize calf diarrhea and improve gut 
health during the preweaning period using alternative approaches to antibiotics is essential.  
In humans, fecal microbial transplantation (FMT), which is the transfer of fecal 
material from a healthy donor into the gastrointestinal tract (GIT) of a recipient with an 
enteric condition (de Groot et al., 2017) has been used.  FMT has been highly successful in 
curing enteric  diseases such as irritable bowel syndrome and Crohn’s disease in humans 
(Ponte et al., 2015, Suskind et al., 2015). FMT has the capacity to shift microbial taxa and 
to restore gut microbiota in humans. (Kelly et al., 2014). Currently, there are very few FMT 
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studies in the animal science field, including companion animals (Pereira et al., 2018) and 
livestock (Hu et al., 2018a) .  
From a health standpoint, the host immune system and the commensal bacteria 
present in the GIT need to be in equilibrium; otherwise, disruption of this balance may 
cause dysbiosis, and an inflammatory response in the host might be triggered (Kamada et 
al., 2013). However, the understanding of microbial communities and their interactions 
with the host in neonatal calves during the preweaning in terms of gut health and 
development is very limited. Therefore, we hypothesized that neonatal gut inoculation with 
a healthy adult gut microbiota could improve GIT development and maturation early in 
life. Thus, the objective of this study was to evaluate the effects of performing fecal 
microbiota transplantation in neonatal dairy calves on growth and health performance, and 
in the immune status. 
MATERIALS AND METHODS 
 
Experimental design 
 
The Institutional Animal Care and Use Committee (IACUC) of the South Dakota 
State University (SDSU) approved all procedures for this study (protocol#A3958-01). 
This study comprised of a pre-trial phase and a trial phase. The fecal material from the 
selected cow donor was used in both phases of the study. 
Donor Selection and fecal preparation 
 
A group of 5 lactating Holstein cows was pre-selected from the herd at SDSU 
Dairy Research and Training facility as potential donors under the following criteria: 1) 
high milk yield production; 2) multiparous cows over 3 lactations ; 3) no clinical history of 
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any disease (e.g., retained placenta, mastitis, etc.) during any lactation. Fecal samples were 
collected from each cow, immediately kept on ice, and sent to the Animal Disease 
Research and Diagnostic Laboratory at SDSU for analysis of infectious pathogens and 
other risk factors. The stool testing included aerobic culture, fecal float for ova, and PCR 
detection for the presence of Mycobacterium paratuberculosis, Salmonella, and 
Cryptosporidium. From this group of pre-selected cows, one cow was negative for all the 
fecal pathogens measured and had no clinical history of any disease during 5 lactations at 
SDSU; therefore, this cow was designated as the donor. The final fecal material from the 
donor was collected via rectum stimulation, immediately frozen in liquid nitrogen, and 
stored at -80°C until the inoculation day.  
Pre-trial phase: experimental design 
 
Four healthy newborn Holstein calves from the SDSU Dairy Research and 
Training facility were randomly selected if they met the following criteria: 1) between 2 
and 4 weeks of age; 2) fecal score ≤ 2 [scale from 1 – 4, 1:well-formed-solid feces; 2:soft, 
pudding-like; 3: runny, pancake batter; 4: liquid, splatters;  (Osorio et al., 2012a)]. Calves 
received one FMT inoculation via milk replacer in the morning feeding, and health records 
were collected for 5 consecutive days. Calves received 25 g of fecal material from the 
donor. The proposed 25 g of fecal material was derived from previous FMT performed in 
humans [~70.55 kg BW of adult (Walpole et al., 2012)]. On the inoculation day, fecal 
material was thawed in a warm (37°C) water bath as described by other studies (Hu et al., 
2018a, Wang et al., 2019). After the inoculation day, health checks were measured daily, 
including fecal score (scale from 1 – 4), rectal temperature, and respiratory score [scale 1 – 
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5, 1: normal; 2: runny nose; 3: heavy breathing; 4: cough moist; 5: cough dry; (Osorio et 
al., 2012)]. There was no adverse effect on milk replacer intake, calf scours did not 
increase, and the maximum rectal temperature observed was 39°C (Figure 4.1), whereas 
there was no need to use anti-inflammatory medication for fever (not higher than 39°C). 
Thus, no adverse effects were detected during the pre-trial phase, we proceeded with the 
trial phase of this study.  
Trial phase: experimental design and fecal microbiota inoculations 
 
Sixteen healthy newborn Holstein calves (n = 8/TRT) from the SDSU Dairy 
Research and Training facility were used for the trial phase in a completely randomized 
design (CRD) experiment from birth to 7 weeks of age. Calves were enrolled in the 
experiment if they fit the following criteria: calving difficulty < 3, single calf, and calf birth 
weight ≥ 36 kg were. Calves were processed within 4 hours after birth; calf handling 
included weighing, vaccinated with CALF-GUARD® (Bovine Rota-Coronavirus vaccine, 
Zoetis, MI), navel disinfected with 7% tincture of iodine solution (First priority Inc., Elgin, 
IL), and received 3.8 L of high-quality colostrum (> 60 mg/L) colostrum. Calves were 
housed in individual hutches bedded with straw and had ad libitum access to water and 
antibiotic-free starter grain (Calf 20 Nonmed®; 20% CP, Purina Animal Nutrition, MN) 
throughout the experiment. Calves were randomly assigned to a control treatment (CON) 
receiving 2.8 L of a commercial antibiotic-free milk replacer (Herd Maker®PB; Land 
O’Lakes Animal Milk products, MN) twice daily, while calves subjected to the FMT 
received the same regimen of milk replacer; however, during 8 to 12 d of age the morning 
milk replacer was inoculated with 25 g fecal material from the donor. On the first 
inoculation day, fecal material was thawed in a warm (37°C) water bath as described by 
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other studies (Hu et al., 2018a, Wang et al., 2019), and subsequent homogenous aliquots 
were kept at -20°C for the following 4 consecutive inoculations. After the 5th FMT 
inoculation, calves received the same feeding program and management as CON calves. 
During the 6 wk of age, all calves received milk replacer once a day and were completed 
weaned at 7 wk of age. 
Animal measurements 
 
Growth performance, including body weight (BW) and withers height, were 
recorded weekly before morning feeding. Health evaluations, including fecal score [scale 1 
– 4], rectal temperature, and respiratory score [scale 1–5] were recorded daily throughout 
the experiment. Individual intakes of milk replacer, starter grain, and water were measured 
and recorded daily throughout the trial.  
Blood sample collection 
 
Blood samples were collected prior to morning feeding from the jugular vein using 
20-gauge BD vacutainer needles (Becton Dickinson, Franklin Lakes, NJ). Samples were 
collected into evacuated tubes (10 mL, BD Vacutainer®) containing either serum clot 
activator or lithium heparin. The first blood sample was collected at 24 h after birth (i.e., 0 
wk), and subsequent samples were taken weekly until 7 wk. After blood collection, tubes 
with lithium heparin were placed on ice (4 °C), and tubes with clot activator were kept at 
21°C (~30 min) until centrifugation. Serum and plasma were obtained by centrifugation of 
clot activator and lithium heparin tubes, respectively, at 1,300 × g for 15 min at 4 °C. 
Aliquots of serum and plasma were frozen (-80°C) until further analysis. 
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Blood biomarkers 
 
Blood samples were analyzed for energy metabolites [i.e., glucose, β-
hydroxybutyric acid (BHB)], muscle mass catabolism (i.e., urea and creatinine), liver 
function [i.e., albumin, cholesterol, total bilirubin, gamma-glutamyl transferase (GGT), 
paraoxonase (PON), glutamic-oxaloacetic transaminase (GOT)], inflammation [i.e., 
haptoglobin, ceruloplasmin, Interleukin (IL)-6, and IL-1β], and oxidative stress [i.e., 
reactive oxygen metabolites (ROM), ferric reducing antioxidant power (FRAP)] using kits 
purchased from Instrumentation Laboratory (Lexington, MA) following the procedures 
described previously (Trevisi et al., 2012, Batistel et al., 2016, Jacometo et al., 2016). 
Polymorphonuclear leukocytes (PMNL) isolation  
 
The PMNL were isolated based on procedures described by Rosa and Osorio 
(2019b). Briefly, blood samples (~100 mL) were collected from the jugular vein prior to 
morning feeding  at 0, 1, 2, and 3 wk of age using a scalp vein butterfly (Excel 
International, CAT# 26702) into evacuated tubes containing ACD solution A (BD, Cat# 
268426) and mixed well by inversion and placed on ice until isolation. Samples were 
centrifuged at 600 × g for 30 min at 4 °C. The plasma, buffy coat, and ~ one-third of the 
red blood cells were discarded. The remaining sample was poured into a 50-mL conical 
tube (Fisher Scientific, Pittsburgh, PA). Twenty-five milliliters of deionized water at 4 °C 
was added to lyse the red blood cells (RBC), followed by addition of 5 mL of 5 × PBS at 4 
°C to restore an iso-osmotic environment. Samples were centrifuged at 900 × for 10 min at 
4°C, the supernatants were decanted, and the cell pellet was washed twice with 10 mL of 1 
× PBS at 4°C. The cell suspension was centrifuged at 900 × for 5 min at 4°C, and the 
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supernatants were discarded. The remaining RBC were lysed with 8 mL of ice-cold 
deionized water, homogenized gently by inversion and 2 mL of 5 × PBS at 4°C was added. 
The samples were centrifuged at 900 × for 5 min at 4°C, and the supernatant was discarded. 
Subsequently, samples were washed twice using 10 mL of 1 × PBS at 4°C were performed, 
followed by centrifugation 900 × for 5 min at 4°C. The PMNL pellet was homogenized 
with 1.5 mL of 1 × PBS at 4°C, transferred to a 2-mL RNase-DNase-free microcentrifuge 
tube and centrifuged at 6,000 × g (Sorvall Legend Microcentrifuge 21R) for 5 min at 4°C. 
The final PMNL pellet was homogenized in 1 mL of Trizol reagent (Ambion, Carlsbad, 
CA) and stored at -80 °C until further gene expression analysis.   
Viability analysis of PMNL through flow cytometry 
 
During the PMNL isolation process, an aliquot containing at least 500,000 cells 
[counted via an automated cell counter (Countess II FL Cell counter from Life 
Technologies)] was used for PMNL quantification and viability. The PMNL aliquots were 
incubated for 30 min at 4°C with a primary antibody for granulocytes (CH138A, 
Veterinary Microbiology and Pathology, Washington State University) followed by another 
30 min incubation at 4°C with a secondary antibody (Goat Anti-Mouse IgM, human ads-
PE, Southern Biotech). Cells were fixed with 150 µL of 4% paraformaldehyde (Sigma-
Aldrich) and preserved at 4°C until analysis. Flow cytometry data were acquired with the 
Attune NxT cytometer (Attune® NxT Flow Cytometer, Invitrogen), and the panel with the 
cell population of interest was analyzed using the Attune NxT cytometer software.  
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RNA isolation, cDNA synthesis, and Quantitative PCR (qPCR) 
 
Total RNA was extracted from blood PMNL using Trizol (Invitrogen, Cat# 15-596-
026) reagent in combination with the RNeasy® Plus Mini Kit (Qiagen, Cat#74134), 
following the manufacturer’s instructions with some modifications. Briefly, the cell pellet 
immersed in TRIzol was transferred to a 2-mL RNase-DNase-free O-ring tube, containing 
one stainless steel bead, 5 mm (Qiagen, Cat#69989) and homogenized in a Beadbeater 
(BioSpec Products, Cat#BSP74540) for 30s. After homogenization, the lysate was 
transferred to a 2-mL RNase-DNase-free microtube and 200µL of Phenol:chloroform 
(Invitrogen™, Cat#AM9730) at 4 °C was added in order to isolate the RNA from the 
organic phase. After centrifugation at 13,000 x g for 15 min at 4 °C, the upper phase 
supernatant was transferred into a new 2-mL RNase-DNase-free microtube. The total RNA 
was purified RNeasy® Plus Mini Kit and eluted in 50 µL of RNase-free water. The RNA 
quantity (111.13 ± 102.23 ng/µl; mean ± SD) and purity as 260/280 ratio (1.85 ± 0.15) 
were determined using Nanodrop.  
The complementary DNA (cDNA) synthesis was performed according to Bionaz 
and Loor (2007). The cDNA was then diluted 1:4 with RNase-DNase-free water (HyClone, 
UltraPure™, Cat#10977015). The qPCR was performed in a MicroAmp Optical 384-Well 
Reaction Plate (Applied Biosystems, Grand Island, NY). Within each well, 4µL of diluted 
cDNA combined with 6µL of a mixture composed of 5 µL 1×SYBR Green master mix 
(Applied Biosystems, Woolston Warrington, UK), 0.4µL each of 10µM forward and 
reverse primers, and 0.2 µL of DNase/RNase-free water. Three replicates were run for each 
sample and a non-template control was run for each gene analyzed. The qPCR reaction was 
conducted in QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems) 
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following the conditions: 2 min at 50C, 10 min at 95C, and 40 cycles with 15s at 95C 
followed by 1 min at 60C. A dissociation curve was performed (gradient from 95C to 
60C to 95C for 15s) to check for amplicon quality. 
For this study, relative mRNA expression of each gene was calculated based on a 
six-point relative standard curve and the internal control genes (ICG) used were golgin 
subfamily A, member 5 (GOLGA5), oxysterol-binding protein-like 2 (OSBPL2), and 
single-strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1), which have 
been previously used to normalize PMNL gene expression data (Moyes et al., 2010). The 
geometric mean of the ICG was used to normalize the expression of the target genes. The 
stability of the ICG was assessed using the geNorm software (Vandesompele et al., 2002) 
with a favorable final pairwise variation of 0.20. The target genes measured within the 
PMNL samples in this study are described in Table 4.1. 
Statistical analysis 
 
Data were analyzed using the PROC MIXED procedure of SAS 9.4 (SAS Institute, 
Inc., Cary, NC, USA). The model included treatment (TRT; CON and FMT), time (day or 
week), and their interaction as fixed effects, and calf as a random effect. The autoregressive 
(1) covariance structure was used for repeated measures for all parameters analyzed. Blood 
metabolites and gene expression results were log-scale transformed if needed, in order to 
comply with a normal distribution of residuals. Baseline samples taken at 24 h after 
colostrum intake or 0 wk were used as a covariate in the model if they were significant (P < 
0.05). A priori orthogonal contrasts were used to determine linear and quadratic effects 
over time whenever at least a trend (P ≤ 0.10) for a treatment × week (TRT × Week) was 
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observed. Statistical significance and tendencies were declared at P ≤ 0.05 and P ≤ 0.15, 
respectively. 
RESULTS 
 
Growth performance and health 
 
Main effects of TRT, time, and their interaction for growth performance and health 
parameters are presented in Figure 4.2. There was a trend (P = 0.09) for greater BW (50.8 
vs 52.7 kg±0.7) in FMT calves in comparison to CON. Similarly, there was a trend (P = 
0.13) for greater WH in FMT (82.6 vs 83.8 kg ± 0.49) calves in comparison to CON. 
Starter intake and average daily gain (ADG) were not affected by treatment effects; 
however, they increased over time (P < 0.01) (Figure 4.3). Fecal scores and rectal 
temperature were not affected (P ≤ 0.65) by FMT inoculation (Figure 4.4). 
Blood biomarkers 
 
Main effects of treatment, time, and their interaction for blood biomarkers of 
energy metabolism, inflammation, liver function, and oxidative stress are presented in 
Table 4.2.  
Energy metabolism. The blood concentrations of glucose, BHBA, and creatinine 
were not affected (P ≥ 0.20) by treatment (Table 4.2). A trend (P = 0.07) for a TRT × Week 
was observed for urea. 
Inflammation. There was a TRT × Week (P = 0.02) for haptoglobin, and this was 
reflected by a positive quadratic (P = 0.04) effect observed on FMT treatment only, and 
this was particularly evident at 2 wk, where FMT calves had greater (P = 0.01) 
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concentration of haptoglobin when compared with CON calves (Figure 4.2). Similarly, a 
trend for a TRT × Week (P = 0.07) was observed for IL-1 in blood (Figure 4.5), which 
was reflected in a trend (P = 0.07) for a positive quadratic effect in FMT calves only, while 
IL-1 I in CON tended (P = 0.07)  to have a linear increase over time (Figure 4.5). 
Ceruloplasmin was not affected (P = 0.51) by treatment effects. Blood IL-6 decrease (P < 
0.01) gradually regardless of treatment was observed in blood IL6 over time (Table 4.2). 
Liver function. There was a TRT × Week (P ≤ 0.14) for albumin, paraoxonase, 
and total bilirubin. In the case of albumin, FMT calves tended (P ≤ 0.10) to have lower 
albumin than CON at 1 and 2 wk of age; however, albumin was similar (P = 0.89) in both 
groups by 3 wk (Figure 4.5). The latter was reflected in a greater rate of increase in 
albumin concentration from wk 1 to 3 in FMT calves than CON (6.2% vs. 3.5%, 
respectively). The TRT × Week (P = 0.06) in paraoxonase, which was explained by greater 
(P < 0.01) paraoxonase in FMT calves than CON at 3 wk of age (Figure 4.5). There was a 
trend for a TRT × week (P = 0.13) effect on total bilirubin, which can be explained by a 
trend (P = 0.06) for lower total bilirubin in FMT calves at 1 wk of age when compared to 
CON. Cholesterol, GOT, and GGT were not affected (P ≥ 0.25) by treatment effects. 
Cholesterol and GOT increased (P < 0.01) over time, while GGT decreased (P < 0.01; 
Table 4.2). 
Oxidative stress. No effects (P ≥ 0.20) were observed for ROM and FRAP (Table 
4.2).   
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PMNL gene expression  
 
Pro-inflammatory signaling and cell adhesion genes. Main effects of treatment, 
time, and their interaction on mRNA expression in PMNL are reported in figure 4.6. 
Overall, FMT calves had greater (P = 0.03) expression of ZBP1 than CON, and to a 
lesser extent, FMT calves tended (P = 0.12) to have greater NFKB1 than CON. The 
expression of STAT3 and SELL was not affected by treatment. 
Pathogen recognition and cytokines. Main effects of treatment, time, and their 
interaction on mRNA expression in PMNL are reported in figure 4.7. A trend for a TRT × 
week (P = 0.11) was observed for the TLR2 expression, which was reflected on a trend (P 
= 0.11) for greater TLR2 in FMT calves than CON at 2 wk of age. Overall, IL8 
expression decreased (P = 0.01) over time in all animals. The expression of TLR4 and 
IL1B was not affected by treatment or time. 
DISCUSSION 
 
Animal Performance 
 
We reported for the first time the use of FMT in neonatal dairy calves. The 
procedure proved to be safe with no adverse effects, including no milk refusal, no 
increase in rectal temperature, or respiratory score in FMT animals. These results are in 
agreement with other FMT studies in swine and companion animals (Xiao et al., 2017, 
Pereira et al., 2018). Regarding gastrointestinal signs, no severe diarrhea (FS = 4) was 
observed during the trial, and the fecal score was not affected by FMT, suggesting that 
FMT can be a safe procedure. However, further studies are needed to confirm this lack of 
effect on fecal scores.  
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To our knowledge, our study is the first experiment in dairy calves that attempted 
to evaluate the effects of performing FMT on calf performance (i.e., body conformation 
and feed intake). The tendency for greater BW and WH observed in the treated calves 
suggest that FMT can enhance growth performance. In contrast to BW and WH, the lack 
of treatment effects on starter intake suggests that FMT might improve feed efficiency 
and animal performance. Our findings regarding animal performance are in accordance 
with other studies that performed FMT in young livestock animals. For instance, Hu et al. 
(2018b) orally inoculated newborn pigs from day 1 to day 11 of life with a fecal 
suspension from a healthy donor, and the recipient piglets had greater average daily gain 
than the control piglets. Also, the incidence of diarrhea decreased in the FMT group when 
compared with the control piglets. Additionally, fecal inoculations from a highly feed-
efficient donor chicken into broiler chickens early in life tended to increase feed intake 
and body weight in the FMT recipients chickens (Siegerstetter et al. 2018). 
Biomarkers of inflammation and liver function 
 
The acute phase response is triggered by an inflammatory condition, and it is 
regulated by several cytokines such as IL1- which is produced by immune cells (i.e., 
dendritic cells and macrophages) present in the inflamed tissue (Murata et al., 2004). In 
the small intestine, epithelial cells in the inner surface (i.e., enterocytes) can release 
cytokines (e.g., IL-6) upon inflammation, which stimulates the production of the acute 
phase proteins (APPs) by hepatocytes and other tissues (Pritts et al., 2002). In the 
neonatal liver, the synthesis of APPs can be related to liver maturation rather than a 
disease-related process (Orro et al., 2008), which makes the interpretation of APPs in 
neonates cumbersome. Regardless of treatment, the high IL-6 concentration after birth 
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could be attributed to an activation of the immune system due to colostrum ingestion and 
adaptation to an extrauterine environment. Then, the decline in IL-6 over time could be 
related to the consolidation of the active immunity in the newborn calves, which agrees 
with the results observed by Jacometo et al. (2016). In the current study, the greater 
haptoglobin in FMT calves at 2 wk of age confirms that fecal inoculations between 8 and 
12 d of age challenged the host to some extent. This is in agreement with Bertoni et al. 
(2009), where they reported that haptoglobin greater than 0.2 g/L in blood of neonatal 
calves is associated with an inflammatory condition. However, the haptoglobin 
concentration in FMT calves was modest when compared with other studies, where dairy 
calves were challenged with an infection (Haptoglobin = 1.23g/L) or undergoing a mild 
diarrhea (Haptoglobin = 0.35g/L) (Silva et al., 2011, Rosa et al., 2018). The fact that IL-
1β in FMT calves have a similar pattern as haptoglobin at 2 wk of age concomitantly with 
the lack of FMT effect on IL-6 over time, is an indicative of a local inflammatory 
condition rather than systemic inflammation.  
The anti-inflammatory enzyme paraoxonase (PON) blood levels increased over 
time healthy neonatal calves; in calves of 7 d of age average concentration of PON in 
blood was 8.9±5.2 U/mL (mean±SD) and in calves with 28 d of age the concentration 
was 42.8±14.8 U/mL (Giordano et al. (2013). However, when calves demonstrated a 
degree of inflammation (i.e., diarrhea or respiratory disease), the average PON observed 
in the blood of sick calves was 3.7±1.4 U/mL at 7 d of age and 24.5±13.4 U/mL at 28 d 
of age. Thus, there is a significant difference in PON concentration in healthy vs. sick 
(i.e., inflammatory condition) neonatal calves. 
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The hepatic metabolic activity in neonatal calves is lower than the adult ruminant 
(Baldwin et al. 2004). This can be partially explained by the alterations in the 
metabolizable substrates by the liver from pre-ruminant to ruminant (i.e., glucose and 
fatty acids vs. short-chain fatty acids [SCFA] due to rumen development). In this context, 
the shift from glucose intestinal absorption during pre-weaning period to SCFA, ketones, 
and microbial protein absorption in an adult ruminant lead to changes in the hepatic 
function and energy metabolism during the transition from pre- to- ruminant, including 
the reduction in enzyme activity of glucose oxidation in the liver (Baldwin et al., 2004).  
Thereby, the synthesis of proteins, including the acute phase (i.e., albumin, paraoxonase) 
in the liver during the neonatal stage can be associated with liver development. This can 
be attributed to metabolic adaptations and immune stimulation leading to maturational 
changes of the hepatic organ during the pre-weaning phase (Orro et al., 2008, Giordano et 
al., 2013).  
There is also an increase in blood albumin and paraoxonase from birth to weaning 
(i.e., 5wk of age) of dairy calves (Jacometo et al., 2016, Rosa et al., 2018). Others have 
reported that decreased liver function can be associated with albumin less than 30 g/L in 
blood (Bertoni et al., 2009).  Therefore, the greater paraoxonase concentration in FMT 
calves suggests a positive effect on the liver maturation. Similarly, the greater rate of 
increase for albumin in FMT calves suggests a positive effect of fecal microbial 
inoculations in liver function.  
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PMNL gene expression 
 
The ZBP1 gene encodes the protein Z-DNA binding protein 1, which plays a role 
in sensing cell death and microbial pathogens, including viruses that are not recognized 
by TLR2 or TLR4 (Kuriakose and Kanneganti, 2018). Overall, the increase in ZBP1 
expression between birth and 7 d of age could have been linked with a transient 
inflammatory response triggered by colostrum intake and other conditions such as 
environmental pathogens exposure during the first wk of life. However, the decreased in 
its expression after FMT (8-12 d of age) can be attributed to the regulation of the innate 
immune response, since the release of pro-inflammatory cytokines upon TLR pathway is 
initiated is essential for neutrophil pathogen recognition and activation (Sabroe et al., 
2005, Takaoka et al., 2007), which can be associated with the lack of acute or systemic 
inflammation (i.e., unresponsive IL-6 to FMT effect) during the trial.  
Although calves in the FMT group tended to have greater NFKB1 expression, that 
response was not associated with an upregulation of pro-inflammatory pathways as 
indicated by the lack of response to FMT in STAT3, SELL, TLR4, IL1B, and IL8 
expression. Taken together, these results seem to support that fecal inoculations starting 
at 8 d of age triggered a mild to moderate inflammatory response that allowed FMT 
calves to maintain a higher expression of the activators of the immune system and further 
upregulation of pro-inflammatory signaling genes was not warranted. Similarly, lower 
expression of pro-inflammatory  mediators, including NFKB1 and MYD88, low IL1B 
expression, and lack of change in the expression of TNFA in PMNL isolated was seen in 
neonatal dairy calves in response mineral supplementation (Jacometo et al. 2015). 
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CONCLUSIONS 
 
This study demonstrated that early life fecal microbiota transplantation into 
neonatal dairy calves is a relatively safe method and can influence calf growth and 
development. Taken together, these data demonstrated that FMT performed using fecal 
material from a selected donor (elite cow of the herd) improved the hepatic maturation 
due to the increase in acute phase protein synthesis during calf neonatal stage. Based on 
the pattern of the biomarkers of inflammation in calves subjected to FMT, there is 
evidence that FMT is less likely to cause an acute or systemic inflammatory response, 
and perhaps it can modulate the transition from a passive immunity (i.e., colostrum) to an 
active immunity in neonatal calves. The precise biological mechanisms being altered by 
fecal microbiota inoculations in neonatal calves remains to be determined; however, the 
evidence for such alterations is underpinned by the seemly improved growth in FMT 
calves. Additional research in this area is needed to confirm our results and shed light on 
putative biological mechanisms on the FMT response observed in the current study.  
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Table 4.1 Genes selected for transcript profiling in bovine polymorphonuclear leukocytes 
(PMNL). 
Gene Name Symbol Function 
Nuclear Factor of Kappa Light 
Polypeptide Gene Enhancer In 
B-Cells 1 
NF-KB1 
NF-kappa-B is a pleiotropic transcription factor present in 
almost all cell types and is the endpoint of a series of signal 
transduction events that are initiated by a vast array of 
stimuli related to many biological processes such as 
inflammation, immunity, differentiation, cell growth, 
tumorigenesis, and apoptosis. 
Signal Transducer and Activator 
of Transcription 3 (Acute-Phase 
Response Factor) 
STAT3 
This protein is activated through phosphorylation in 
response to various cytokines and growth factors including 
IFNs, EGF, IL5, IL6, HGF, LIF, and BMP2. This protein 
mediates the expression of a variety of genes in response to 
cell stimuli, and thus plays a key role in many cellular 
processes such as cell growth and apoptosis. 
Leukocyte-Endothelial Cell 
Adhesion Molecule 1 
SELL 
This gene encodes a cell surface adhesion molecule that 
belongs to a family of adhesion/homing receptors. The 
gene product is required for binding and subsequent rolling 
of leucocytes on endothelial cells, facilitating their 
migration into secondary lymphoid organs and 
inflammation sites.  
Interleukin 1 B IL1B 
Produced by activated macrophages, IL-1 stimulates 
thymocyte proliferation by inducing IL-2 release, B-cell 
maturation and proliferation, and fibroblast growth factor 
activity. Potent proinflammatory cytokine.  
Z-DNA Binding Protein 1 ZBP1 
This gene encodes a Z-DNA binding protein. The encoded 
protein plays a role in the innate immune response by 
binding to foreign DNA and inducing type-I interferon 
production.  
Toll-Like Receptor 2 TLR2 
The protein encoded by this gene is a member of the Toll-
like receptor (TLR) family which plays a fundamental role 
in pathogen recognition and activation of innate immunity.  
Toll-Like Receptor 4 TLR4 
The protein encoded by this gene is a member of the Toll-
like receptor (TLR) family which plays a fundamental role 
in pathogen recognition and activation of innate immunity. 
This receptor has been implicated in signal transduction 
events induced by lipopolysaccharide (LPS) found in most 
gram-negative bacteria. Mutations in this gene have been 
associated with differences in LPS responsiveness 
Interleukin 8 IL8 
Also, referred to as CXCL8 (C-X-C Motif Chemokine 
Ligand 8). It is a chemotactic factor that attracts 
neutrophils, basophils, and T-cells, but not monocytes. It is 
also involved in neutrophil activation. It is released from 
several cell types in response to an inflammatory stimulus. 
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Table 4.2 Blood immunometabolic biomarkers during neonatal period in Holstein dairy 
calves under a conventional nutritional program (CTR) or subjected to five days of fecal 
microbiota inoculations (FMT) within antibiotic-free milk replacer. 
 Group2  P-value4 
Parameter1 CTR FMT SEM3 TRT Week TRT × week 
Energy metabolism       
   Glucose, mmol/L 6.23 5.69 0.34 0.33 0.04 0.28 
   BHBA5, mmol/L 0.09 0.07 0.01 0.20 0.36 0.28 
   Creatinine, mol/L 94.65 91.75 4.41 0.65 0.03 0.72 
   Urea, mmol/L 2.98 2.74 0.16 0.29 0.01 0.07 
Inflammation       
   Haptoglobin, g/L 0.191 0.212 0.01 0.24 0.06 0.02 
   Ceruloplasmin, mol/L 1.82 1.95 0.13 0.51 0.38 0.29 
   IL1- (Log2) pg/mL 3.69 3.67 0.39 0.98 0.26 0.07 
   IL-6, (Log2) pg/mL 8.17 7.96 0.20 0.48 < 0.01 0.68 
Liver function       
   Albumin, g/L 30.61 30.03 0.29 0.18 < 0.01 0.14 
   Paraoxonase, U/mL 34.50 40.56 2.19 0.07 < 0.01 0.06 
   Total bilirubin, mol/L 4.67 6.30 0.97 0.26 < 0.01 0.13 
   Cholesterol, mmol/L 2.68 2.40 0.17 0.25 < 0.01 0.31 
   GOT6 (Log2), U/L 5.76 5.89 0.11 0.42 < 0.01 0.71 
   GGT7, U/L 458.42 418.14 87.38 0.76 < 0.01 0.16 
Oxidative Stress       
   ROM8, mg H2O2/100 mL 12.06 12.09 0.60 0.98 0.23 0.20 
   FRAP9, mmol/L 160.45 149.64 7.79 0.36 0.46 0.34 
1Metabolites and biomarkers were analyzed from 1 to 3 week of age. 2CTR = control; FMT 
= fecal microbial transplantation; 3Largest SEM is shown; 4P-value for treatment (TRT), 
week, or either interaction (TRT × week); 5BHBA = β-hydroxybutyric acid; 6GOT = 
glutamic-oxaloacetic transaminase; 7GGT = -glutamyltransferase; 8ROMt = reactive 
oxygen metabolites; 9FRAP = ferric reducing antioxidant power. 
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Figure 4.1 Rectal temperature (°C) after a fecal microbiota transplantation (FMT) within 
antibiotic-free milk replacer into neonatal Holstein calves during a pre-trial phase of 4 
days. 
 
 
  
71 
 
 
 
Figure 4.2 Growth performance from birth (week 1 f age) to weaning (7 weeks of age) of 
Holstein dairy calves under a conventional nutritional program (Control) or subjected to 
five days of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer 
from 8 d to 12 days of age. The P-values for main effects of treatment (TRT) and week, 
and their interaction (TRT x Week) are shown in each plot. Values are means with 
standard errors represented by vertical bars. 
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Figure 4.3 Performance parameters from birth to weaning of Holstein dairy calves under 
a conventional nutritional program (Control) or subjected to five days of fecal microbiota 
inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12 days of age. The 
P-values for main effects of treatment (TRT) and week or day, and their interaction (TRT 
x Week; TRT x Day) are shown in each plot. Values are means with standard errors 
represented by vertical bars. 
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Figure 4.4 Health parameters from birth to weaning of Holstein dairy calves under a 
conventional nutritional program (Control) or subjected to five days of fecal microbiota 
inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12 days of age. The 
P-values for main effects of treatment (TRT) and day, and their interaction (TRT x Day) 
are shown in each plot. Values are means with standard errors represented by vertical 
bars. 
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Figure 4.5 Inflammatory [Haptoglobin and interleukin 1 beta (IL1-β)] and liver function 
biomarkers [albumin and paraoxonase) during the neonatal period in Holstein dairy 
calves under a conventional nutritional program (Control) or subjected to five days of 
fecal microbiota inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12 
days of age. The P-values for main effects of treatment (TRT) and week, and their 
interaction (TRT x Week) are shown in each plot. The TRT x Week effect (P ≤ 0.10) 
were further analyzed through orthogonal contrast in order to determine linear (L) and 
quadratic (Q) effects. A significant difference (P < 0.05) between treatments in a specific 
time point was denoted by an asterisk (*). Values are means, with standard errors 
represented by vertical bars. 
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Figure 4.6 Expression of genes related to pro-inflammatory signaling cascade (ZBP1, 
NFKB1, STAT3) and cell adhesion (SELL) in polymorphonuclear leukocytes (PMNL) of 
dairy calves under a conventional nutritional program (Control) or subjected to five days 
of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer from 8 d to 12 
days of age. The P-values for main effect of treatment (TRT) and week and TRT*Week 
are shown. Data before week 1 of age are from samples 24 hours after birth (baseline). 
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Figure 4.7 Expression of genes associated with pathogen recognition (TLR2 and TLR4) 
and pro-inflammatory cytokines (IL1B and IL8) in polymorphonuclear leukocytes 
(PMNL) of dairy calves under a conventional nutritional program (Control) or subjected 
to five days of fecal microbiota inoculations (FMT) within antibiotic-free milk replacer 
from 8 d to 12 days of age. The P-values for main effect of treatment (TRT) and week 
and TRT*Week are shown. Data before week 1 of age are from samples 24 hours after 
birth (baseline). 
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OVERALL SUMMARY AND CONCLUSION 
 
The research presented accomplished the overall objective, which was: a) to 
validate and optimize a non-invasive method to investigate transcriptomic changes in the 
gastrointestinal tract of neonatal dairy calves; b) to evaluate the effects of an early life 
fecal microbiota transplant on growth and health performance on neonatal dairy calves. 
The results in Chapter 2 indicated that RNA isolated from fecal samples contain a low 
number of immune cells such as PMNL and further confirms the signal observed in genes 
related to inflammation in fecal samples. Interestingly, the mRNA abundance of 99.55% 
detected for the gene marker for immune cells SELL within the PMNL samples, in 
contrast to the 75.15% abundance of KRT8 gene marker for epithelial cells within fecal 
samples provided new insights on the fecal RNA reliability. 
The results in Chapter 3 indicated that the tight junction complex might affect the 
rumen epithelia in a different manner than the intestinal epithelia based on the contrasting 
expression between ruminal tissue and intestinal tissues for the genes TJP1, CLDN1, and 
CLDN4. Based on the greater expression of genes markers of epithelial cells, FABP2 and 
KRT8 observed in the fecal samples together with the high abundance of CLDN4 mRNA 
in feces further confirm the reliability of transcripts identified in feces with the host. The 
gene expression performed across studies at different fecal scores levels suggests that 
fecal RNA could be a robust technique that can be utilized to investigate physiological 
alterations in non-diarrheic and diarrheic animals. 
Regarding the FMT study, the findings from Chapter 4, demonstrated that early 
life inoculations of fecal material from selected donors into neonatal calves did not 
induce scouring or produced a strong inflammatory condition. Transient and mild 
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increases in pro-inflammatory blood biomarkers, haptoglobin, and IL-1B, suggests that 
fecal inoculations stimulate the innate immune response in neonatal calves. In addition, 
the greater rates of increase in albumin and paraoxonase over time in FMT calves provide 
evidence for an improved hepatic maturation effect on calves subjected to FMT.  
The gene expression in the PMNL samples in Chapter 4 indicated that all animals, 
including control and FMT calves, experienced an inflammatory condition at birth, which 
dwindled over time. Moreover, the lack of effect of FMT on PMNL gene expression 
confirms that such fecal inoculations did not produce an adverse inflammatory condition 
in FMT calves. 
The linear increase in starter (grain pellets) intake over time indicated that FMT 
did not present an adverse effect on solid feed intake. The trend observed on BW and 
WH for greater overall growth on FMT calves provides further evidence for the 
beneficial effects of altering the gut microbiota of neonatal dairy calves.  
Overall, our studies provided new insights on the utilization of fecal material to 
not only improve our understanding of the GIT maturation in neonatal dairy calves but 
perhaps its modification through FMT to enhance growth and welfare. Although our 
results on the early life fecal microbiota transplantation into neonatal dairy calves 
demonstrated positive effects on calf growth and performance, further research is needed 
to investigate the mechanisms through which the immature GIT in neonates interacts with 
the newly colonizing microbiota and correlate these effects with neonatal immunity and 
performance. 
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 An approach such as FMT can be used as a method to manipulate the early life 
GIT microbiota colonization of neonates to prime a more desirable host-microbiota 
development and interaction so that neonates can better face the challenges during the 
first weeks of life. For instance, within a given herd, dairy cows could be selected as elite 
donors, and based on fecal screening and production records (similar to our study), each 
farm can have fecal samples stored for further inoculations into the newborn calves. In 
this way, neonates would acquire adapted and targeted microbiota (i.e., from the same 
environment) from high producing and healthy cows, priming the GIT colonization and 
development during the neonatal stage.  
The inability to take sequential GIT samples over time using a traditional 
postmortem sample collection approach is a limitation to account for the inherent animal 
variation and may restrict the accurate development of models and mechanisms occurring 
over time during enteric infections. Like any other biological process, enteric infections 
such as diarrhea are a dynamic process where time is an important factor. Over time, 
infections in the GIT can lead to the disruption of tight junctions between enterocytes in 
the epithelial barrier, compromising the electrolytes balance, thus, increasing the flux of 
these into the intestinal lumen. The molecular changes underpinning this phenomenon 
occur in the early phases leading to diarrhea. In our research, RNA isolated from feces of 
neonatal dairy calves is proposed as a proxy for GIT gene expression to investigate the 
molecular adaptations to pathogenic infections of the GIT, which could lead to uncover 
key regulatory mechanisms employed by pathogens, which can, in turn, can become 
therapeutic targets based on the new knowledge generate from the fecal RNA method.  
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